Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program.
- Authors
- Taliun, Daniel; Harris, Daniel N; Kessler, Michael D; Carlson, Jedidiah; Szpiech, Zachary A; Torres, Raul; Taliun, Sarah A Gagliano; Corvelo, André; Gogarten, Stephanie M; Kang, Hyun Min; Pitsillides, Achilleas N; LeFaive, Jonathon; Lee, Seung-Been; Tian, Xiaowen; Browning, Brian L; Das, Sayantan; Emde, Anne-Katrin; Clarke, Wayne E; Loesch, Douglas P; Shetty, Amol C; Blackwell, Thomas W; Smith, Albert V; Wong, Quenna; Liu, Xiaoming; Conomos, Matthew P; Bobo, Dean M; Aguet, François; Albert, Christine; Alonso, Alvaro; Ardlie, Kristin G; Arking, Dan E; Aslibekyan, Stella; Auer, Paul L; Barnard, John; Barr, R Graham; Barwick, Lucas; Becker, Lewis C; Beer, Rebecca L; Benjamin, Emelia J; Bielak, Lawrence F; Blangero, John; Boehnke, Michael; Bowden, Donald W; Brody, Jennifer A; Burchard, Esteban G; Cade, Brian E; Casella, James F; Chalazan, Brandon; Chasman, Daniel I; Chen, Yii-Der Ida; Cho, Michael H; Choi, Seung Hoan; Chung, Mina K; Clish, Clary B; Correa, Adolfo; Curran, Joanne E; Custer, Brian; Darbar, Dawood; Daya, Michelle; de Andrade, Mariza; DeMeo, Dawn L; Dutcher, Susan K; Ellinor, Patrick T; Emery, Leslie S; Eng, Celeste; Fatkin, Diane; Fingerlin, Tasha; Forer, Lukas; Fornage, Myriam; Franceschini, Nora; Fuchsberger, Christian; Fullerton, Stephanie M; Germer, Soren; Gladwin, Mark T; Gottlieb, Daniel J; Guo, Xiuqing; Hall, Michael E; He, Jiang; Heard-Costa, Nancy L; Heckbert, Susan R; Irvin, Marguerite R; Johnsen, Jill M; Johnson, Andrew D; Kaplan, Robert; Kardia, Sharon L R; Kelly, Tanika; Kelly, Shannon; Kenny, Eimear E; Kiel, Douglas P; Klemmer, Robert; Konkle, Barbara A; Kooperberg, Charles; Köttgen, Anna; Lange, Leslie A; Lasky-Su, Jessica; Levy, Daniel; Lin, Xihong; Lin, Keng-Han; Liu, Chunyu; Loos, Ruth J F; Garman, Lori; Gerszten, Robert; Lubitz, Steven A; Lunetta, Kathryn L; Mak, Angel C Y; Manichaikul, Ani; Manning, Alisa K; Mathias, Rasika A; McManus, David D; McGarvey, Stephen T; Meigs, James B; Meyers, Deborah A; Mikulla, Julie L; Minear, Mollie A; Mitchell, Braxton D; Mohanty, Sanghamitra; Montasser, May E; Montgomery, Courtney; Morrison, Alanna C; Murabito, Joanne M; Natale, Andrea; Natarajan, Pradeep; Nelson, Sarah C; North, Kari E; O'Connell, Jeffrey R; Palmer, Nicholette D; Pankratz, Nathan; Peloso, Gina M; Peyser, Patricia A; Pleiness, Jacob; Post, Wendy S; Psaty, Bruce M; Rao, D C; Redline, Susan; Reiner, Alexander P; Roden, Dan; Rotter, Jerome I; Ruczinski, Ingo; Sarnowski, Chloé; Schoenherr, Sebastian; Schwartz, David A; Seo, Jeong-Sun; Seshadri, Sudha; Sheehan, Vivien A; Sheu, Wayne H; Shoemaker, M Benjamin; Smith, Nicholas L; Smith, Jennifer A; Sotoodehnia, Nona; Stilp, Adrienne M; Tang, Weihong; Taylor, Kent D; Telen, Marilyn; Thornton, Timothy A; Tracy, Russell P; Van Den Berg, David J; Vasan, Ramachandran S; Viaud-Martinez, Karine A; Vrieze, Scott; Weeks, Daniel E; Weir, Bruce S; Weiss, Scott T; Weng, Lu-Chen; Willer, Cristen J; Zhang, Yingze; Zhao, Xutong; Arnett, Donna K; Ashley-Koch, Allison E; Barnes, Kathleen C; Boerwinkle, Eric; Gabriel, Stacey; Gibbs, Richard; Rice, Kenneth M; Rich, Stephen S; Silverman, Edwin K; Qasba, Pankaj; Gan, Weiniu; NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium; Papanicolaou, George J; Nickerson, Deborah A; Browning, Sharon R; Zody, Michael C; Zöllner, Sebastian; Wilson, James G; Cupples, L Adrienne; Laurie, Cathy C; Jaquish, Cashell E; Hernandez, Ryan D; O'Connor, Timothy D; Abecasis, Gonçalo R
- Year
- 2021
- Journal
- Nature
- PMID
- 33568819
- DOI
- 10.1038/s41586-021-03205-y
- PMCID
- PMC7875770
The Trans-Omics for Precision Medicine (TOPMed) programme seeks to elucidate the genetic architecture and biology of heart, lung, blood and sleep disorders, with the ultimate goal of improving diagnosis, treatment and prevention of these diseases. The initial phases of the programme focused on whole-genome sequencing of individuals with rich phenotypic data and diverse backgrounds. Here we describe the TOPMed goals and design as well as the available resources and early insights obtained from the sequence data. The resources include a variant browser, a genotype imputation server, and genomic and phenotypic data that are available through dbGaP (Database of Genotypes and Phenotypes). In the first 53,831 TOPMed samples, we detected more than 400 million single-nucleotide and insertion or deletion variants after alignment with the reference genome. Additional previously undescribed variants were detected through assembly of unmapped reads and customized analysis in highly variable loci. Among the more than 400 million detected variants, 97% have frequencies of less than 1% and 46% are singletons that are present in only one individual (53% among unrelated individuals). These rare variants provide insights into mutational processes and recent human evolutionary history. The extensive catalogue of genetic variation in TOPMed studies provides unique opportunities for exploring the contributions of rare and noncoding sequence variants to phenotypic variation. Furthermore, combining TOPMed haplotypes with modern imputation methods improves the power and reach of genome-wide association studies to include variants down to a frequency of approximately 0.01%.
Distribution of genetic variants across the genome.Common (allele frequency ≥ 0.5%) and rare (allele frequency < 0.5%) variant counts are shown above and below the x axis, respectively, within 1-Mb concatenated segments (see Methods). Segments are stratified by CADD functionality score, and sorted based on their number of rare variants according to the functionality category. There were 22 high CADD, 22 medium CADD and 34 low CADD coding segments, and 40 high CADD, 238 medium CADD and 2,381 low CADD noncoding segments. Noncoding regions of the genome with low CADD scores (<10, reflecting lower predicted function) have the largest levels of common and rare variation (noncoding plot region, dark and light blue, respectively), followed by low CADD coding regions (coding plot region, dark and light blue, respectively). Overall, the vast majority of human genomic variation comprises rare variation.
Characteristics of singleton clustering patterns.Parameter estimates for exponential mixture models of singleton density. Each point represents one of the four components in one of the 3,000 individuals in the sample, coloured according to the genetically inferred population of that individual. The rate parameters of each component are shown across the x axis, and the lambda parameters (that is, the proportion that the component contributes to the mixture) are shown on the y axis (on a log–log scale). Histograms show the distribution of the lambda and rate parameters for each component. AFR, African ancestry; EAS, East Asian ancestry; EUR, European ancestry.
Retained non-reference ancestral sequences discovered from unmapped reads.a, Length distribution of fully resolved ancestral sequences, coloured by overlap with GENCODE v.29 genic features. b, Percentage of non-reference (alternative) alleles compared with the percentage of non-reference sequence identified per individual, coloured by population group. c, Venn diagram showing the positional concordance with insertions identified using short-read data from two previous studies40,41. The number of sequences specific to each study and that have not been partially resolved in the other studies is given between brackets.
Ancestry, genetic diversity and rare-variant genetic relatedness across the TOPMed studies.Each study label is shaded based on their population group. From the outside moving in each track represents: the unrelated sample size of each study used in these calculations, average admixture values, average number of heterozygous sites in each individual’s genome, average number of singleton variants in each individual’s genome and the average within-study rare-variant (RV) sharing comparisons. The links depict the 75th percentile of between-study rare-variant sharing comparisons. All between-study rare-variant sharing comparisons can be found in Supplementary Fig. 29. The sample size, average heterozygosity, number of singletons, within-cohort rare-variant sharing and admixture values by TOPMed study and population group can be found in Supplementary Table 13. Study name abbreviations are defined in Extended Data Tables 1, 2 and Supplementary Table 20.
Relative increase in singletons and doubletons of the site frequency spectrum across McVicker’s B and the population size inferred from demographic inference using various sample sizes.a, The relative increase in the singleton (left) and doubleton (right) bins of the site frequency spectrum for decreasing percentile bins of McVicker’s B compared with the highest percentile bin of B. The higher percentiles of B indicate weaker effects of selection at linked sites (SaLS). These relative increases are plotted for different sample sizes. b, Each point corresponds to the population size inferred in the last generation of an exponential growth model for Europeans. Demographic inference was conducted with different sample sizes for fourfold degenerate sites (n = 4,718,653 sites) and the highest 1% B sites (n = 10,977,437 sites). Error bars show 95% confidence intervals (see Supplementary Table 14 for parameter values). Ne, effective population size.
| # | Section | Preview |
|---|---|---|
| 60 | Methods — Singleton clustering analysis — Mixture model parameter estimation | The distribution of singletons suggest an underlying nonhomogeneous Poisson process, where the rate… |
| 61 | Methods — Singleton clustering analysis — Mixture model parameter estimation | We estimate the parameters of this mixture (λi,1, …, λi,K, θi,1, …, θi,K) using the… |
| 62 | Methods — Singleton clustering analysis — Mixture model parameter estimation | Now let ki,j indicate which of the four processes generated singleton j in individual i. We… |
| 63 | Methods — Singleton clustering analysis — Mixture model parameter estimation | We then classified the process-of-origin for each singleton according to the following optimal… |
| 64 | Methods — Singleton clustering analysis — Identification of mixture component hotspots | After assigning singletons to the most likely mixture component, we pooled singletons across… |
| 65 | Methods — Singleton clustering analysis — Modelling the relationship between clustering patterns and genomic features | In each 1-Mb window, we calculated the average signal for 12 genomic features (H3K27ac, H3K27me3,… |
| 66 | Methods — Singleton clustering analysis — Modelling the relationship between clustering patterns and genomic features | Where Ya,k,w is the number of singletons in ancestry subsample a of mixture component k in window w… |
| 67 | Methods — Evolutionary genetics of individuals with diverse ancestry — Rare variant sharing | In these analyses, we used 39,722 unrelated individuals that had provided consent for population… |
| 68 | Methods — Evolutionary genetics of individuals with diverse ancestry — Rare variant sharing | To confirm that J is not biased by sample size, we randomly sampled 500 individuals from each of two… |
| 69 | Methods — Evolutionary genetics of individuals with diverse ancestry — Haplotype sharing | We used the RefinedIBD program103 to call segments of identical-by-descent (IBD) sharing of length… |
| 70 | Methods — Evolutionary genetics of individuals with diverse ancestry — Haplotype sharing | We divided the data by study and by population group within each study. In the analyses of IBD… |
| 71 | Methods — Evolutionary genetics of individuals with diverse ancestry — Demographic estimation under selection at linked sites | We selected 2,416 samples from the TOPMed data freeze 3 that (1) had a high percentage of European… |
| 72 | Methods — Evolutionary genetics of individuals with diverse ancestry — Demographic estimation under selection at linked sites | We performed several steps to filter the genome for high-quality neutral sites, which were based on… |
| 73 | Methods — Evolutionary genetics of individuals with diverse ancestry — Demographic estimation under selection at linked sites | We performed demographic inference with the moments105 program by fitting a model of exponential… |
| 74 | Methods — Evolutionary genetics of individuals with diverse ancestry — Demographic estimation under selection at linked sites | we used the resulting theta (also inferred by moments) and a mutation rate106 of 1.66 × 10−8 to… |
| 75 | Methods — Evolutionary genetics of individuals with diverse ancestry — Selection | We started with 39,649 unrelated individuals selected from the TOPMed data freeze 5 for which we had… |
| 76 | Methods — Evolutionary genetics of individuals with diverse ancestry — Selection | population. We analysed each population separately. Only bi-allelic sites with an unambiguous… |
| 77 | Methods — TOPMed imputation panel — Construction | We divided each autosomal chromosome and the X chromosome into overlapping chunks (with chunk size… |
| 78 | Methods — TOPMed imputation panel — Evaluation of imputation accuracy | For all TOPMed individuals, genetic ancestries were estimated using the top four principal… |
| 79 | Methods — TOPMed imputation panel — Evaluation of imputation accuracy | individuals from each super-population in the BioMe TOPMed study, and selected markers on chromosome… |
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| A catalogue of early diverged contemporary human genome variation reveals distinct Khoe-San populations. | Jaratlerdsiri W et al. | — | 2026 | → |
| ACVI-Med, an open source variant interpretation tool for medical genomics. | Stadler M et al. | — | 2026 | → |
| A distinct monocyte transcriptional state links systemic immune dysregulation to pulmonary impairment in long COVID. | Kumar S et al. | — | 2026 | → |
| Advances in haplotype phasing and genotype imputation. | Sun Q et al. | — | 2026 | → |
| A genetic association study of iron absorption in adults of East Asian or Northern European ancestry from the Iron Genes in East Asian and Northern European Adults Study (FeGenes). | Barad A et al. | — | 2026 | → |
| A large-scale genome-wide association meta-analysis for nevus count provides direct insights into the genetics of melanoma. | Jayasinghe GJMSR et al. | — | 2026 | → |
| An agentic system for rare disease diagnosis with traceable reasoning. | Zhao W et al. | — | 2026 | → |
| Analyses of plasma multi-omic data across ancestries identify novel pathways implicated in Alzheimer's disease. | Yang C et al. | — | 2026 | → |
| Ancestral diversity in complex disease genetics: from discovery to translation. | Kuchenbaecker K et al. | — | 2026 | → |
| A new form of diabetes caused by INS mutations defined by zygosity, stem cell and population data. | Tong Y et al. | — | 2026 | → |
| A novel two-sample Mendelian randomization framework integrating common and rare variants: application to assess the effect of HDL-C on preeclampsia risk. | Zhang Y et al. | — | 2026 | → |
| Assessing molecular gene by treatment interactions using a population of neural progenitors exposed to valproic acid and lithium. | Valone JM et al. | — | 2026 | → |
| Association of genetic variation with age at diagnosis in type 1 diabetes. | Vollenbrock CE et al. | — | 2026 | → |
| Association of Polygenic Scores for Glaucoma With Measures of Retinal Ganglion Cell Integrity in Young and Older Adults. | Lee SS et al. | — | 2026 | → |
| A two-sample Mendelian randomization study of the causal relationship between respiratory diseases, gastric cancer risk, and Helicobacter pylori infection. | Kim Y et al. | — | 2026 | → |
| Atypical Depression Is Associated With a Distinct Clinical, Neurobiological, Treatment Response, and Polygenic Risk Profile. | Shin M et al. | — | 2026 | → |
| Blood-based DNA methylation captures variance in adult height. | Hatton AA et al. | — | 2026 | → |
| Blood cell ratio biomarkers of systemic inflammation in chronic obstructive pulmonary disease. | So K et al. | — | 2026 | → |
| Blood PCSK9 Impacts Alzheimer's Disease Risk in an <i>APOE</i> Genotype-Dependent Manner: A Prospective Cohort Study. | Tao Q et al. | — | 2026 | → |
| cellSTAAR: incorporating single-cell-sequencing-based functional data to boost power in rare variant association testing of noncoding regions. | Van Buren E et al. | — | 2026 | → |
| Clinical and genetic features of idiopathic pulmonary fibrosis in a Korean cohort. | Kim C et al. | — | 2026 | → |
| Clonal Hematopoiesis of Indeterminate Potential After Radiation Therapy. | Crants SA et al. | — | 2026 | → |
| CNValidatron: accurate and efficient validation of PennCNV calls using computer vision. | Montalbano S et al. | — | 2026 | → |
| Cross-ancestry comparison of aptamer and antibody protein measures. | Nicholas JC et al. | — | 2026 | → |
| Deciphering CD4+ Naive T cell-mediated divergent pathogenic links between type 2 diabetes and pathologic scarring via an integrated multi-omics approach. | Zhu G et al. | — | 2026 | → |
| Deciphering tissue-specific protein regulation for insights into cardiometabolic disease. | Hartley AE et al. | — | 2026 | → |
| Development and validation of a trans-ancestry polygenic risk score for type 1 diabetes. | Jumentier B et al. | — | 2026 | → |
| Development and Validation of a Type 1 Diabetes Multi-Ancestry Polygenic Score. | Deutsch AJ et al. | — | 2026 | → |
| Differences in microRNA levels across metabo-endotypes reveal novel insights into asthma heterogeneity. | Sharma R et al. | — | 2026 | → |
| Emerging strategies for interpreting variants of uncertain significance (VUS) in amyotrophic lateral sclerosis. | Ahmed M et al. | — | 2026 | → |
| Epilepsy concordance in monozygotic twins: the role of common genetic variants. | Dang YL et al. | — | 2026 | → |
| Expansion of Molecular and Clinical Aspects of EPS8L2 (DFNB106)-Associated Hearing Loss Emphasizes a Potential Therapeutic Window. | Owrang D et al. | — | 2026 | → |
| Exploring socio-economic, biochemical, and genetic factors influencing thyroid status in Indian school-going adolescents. | Nair JM et al. | — | 2026 | → |
| FAVOR 2.0: A reengineered functional annotation of variants online resource for interpreting genomic variation. | Zhou H et al. | — | 2026 | → |
| Gene4Denovo2: an updated platform for human de novo mutations discovery and interpretation. | Zhu Z et al. | — | 2026 | → |
| Genetically determined ancestry associates with morphological and molecular carotid plaque features. | Fahim N et al. | — | 2026 | → |
| Genetically predicted susceptibility to dust-induced lung diseases and risk of autoimmune diseases: a two sample Mendelian randomization study. | Kim Y et al. | — | 2026 | → |
| Genetic Architecture of N-Terminal Pro-B-Type Natriuretic Peptide in a Multiancestry Study Population. | Shetty NS et al. | — | 2026 | → |
| Genetic association and machine learning improve the prediction of type 1 diabetes risk. | McGrail C et al. | — | 2026 | → |
| Genetic associations with placental and pregnancy proteins in maternal serum identify biomarkers for hypertension in pregnancy. | Yan Q et al. | — | 2026 | → |
| Genetic Background Predicts Uveal Melanoma Patients' Outcomes. | Verrier T et al. | — | 2026 | → |
| Genetic contributions to Alzheimer's disease and frontotemporal dementia in admixed Latin American populations. | Acosta-Uribe J et al. | — | 2026 | → |
| Genetic diversity and differentiated adaptive strategies for underrepresented populations at the crossroad of Southeast and East Asia. | Li X et al. | — | 2026 | → |
| Genetic modifiers of APOE-ε4-associated cognitive decline. | Contreras AG et al. | — | 2026 | → |
| Genetic Predictors of Response to Oral Insulin for Type 1 Diabetes Prevention. | You L et al. | — | 2026 | → |
| Genetic predisposition to hand grip strength predicts cognitive decline. | Bercovitch R et al. | — | 2026 | → |
| Genetic screens of imaging-derived kidney volumes identify genes linked to kidney function. | Monteiro-Martins S et al. | — | 2026 | → |
| Genome-wide DNA methylation patterns for indicators of liver steatosis: a longitudinal multiomic study. | Ciantar J et al. | — | 2026 | → |
| Genome-wide gene by sleepiness interaction analysis for sleep apnea. | Nagarajan P et al. | — | 2026 | → |
| Genome-wide investigation of prosody perception: Shared genetic influences between speech rhythm, musical rhythm, and reading traits. | Scartozzi AC et al. | — | 2026 | → |
| Genomic and transcriptomic analyses of aortic stenosis enhance therapeutic target discovery and disease prediction. | Small AM et al. | — | 2026 | → |
| hmmibd-rs: an enhanced hmmIBD implementation for parallelizable identity-by-descent detection from large-scale Plasmodium genomic data. | Guo B et al. | — | 2026 | → |
| Humans with function-disrupting variants in the myostatin gene (MSTN) have increased skeletal muscle mass and strength, and less adiposity. | Herman JL et al. | — | 2026 | → |
| Increased genetic protection against Alzheimer's disease in centenarians. | Bae H et al. | — | 2026 | → |
| Increased prevalence of clonal hematopoiesis in children with sickle cell disease. | Ulloa J et al. | — | 2026 | → |
| Integrated Genomic and Transcriptomic Study Reveals <i>MAPK11</i> and <i>PER1</i> as Important Obesity Susceptibility Genes in a High-Risk Hispanic/Latino Population. | Kim D et al. | — | 2026 | → |
| Integrating natural and engineered genetic variations to decode regulatory influence on blood traits. | Tardaguila M et al. | — | 2026 | → |
| Laboratory and genetic characteristic associated with gallbladder-related outcomes in sickle cell disease in Brazil: results from the REDS-III multicenter cohort study. | Belisário AR et al. | — | 2026 | → |
| Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis. | Hop PJ et al. | — | 2026 | → |
| Large-scale human genomic resources drive innovations toward forensic intelligent source attribution and precision identification. | Wang M et al. | — | 2026 | → |
| Letter to the Editor Regarding Ioannou et al. | Bustos BI et al. | — | 2026 | → |
| Liver single-nucleus multiome profiling reveals cell-type mechanisms for cardiometabolic traits. | Alkhawaja AA et al. | — | 2026 | → |
| Mapping protein variants associated with Alzheimer's disease by mass-spectrometry based <i>de novo</i> sequencing assisted strategy. | Emekeeva DD et al. | — | 2026 | → |
| Mediation of Polygenic Asthma Risk Through Gene Expression. | Natarajan R et al. | — | 2026 | → |
| Metabolomic sweet spot clock predicts mortality and age-related diseases in the Canadian Longitudinal Study on Aging. | Vishnyakova O et al. | — | 2026 | → |
| MetaGLIMPSE: Meta-imputation of low-coverage sequencing data for modern and ancient genomes. | Kumar KH et al. | — | 2026 | → |
| Molecular genotype-phenotype correlation in ACTB- and ACTG1-related non-muscle actinopathies. | Di Donato N et al. | — | 2026 | → |
| Multiancestry Genome-Wide Association Study Identifies Variants in a Zinc Finger Gene Cluster as Novel Regulators of HIV Control. | Awada A et al. | — | 2026 | → |
| Multimodal bHLH-PAS DNA binding controls specificity and drives obesity. | Bersten DC et al. | — | 2026 | → |
| Multiple-testing corrections in case-control studies using identity-by-descent segments. | Temple SD et al. | — | 2026 | → |
| Novel Plasma Proteomic Markers and Risk of Venous Thromboembolism. | Tang W et al. | — | 2026 | → |
| Orthrus: toward evolutionary and functional RNA foundation models. | Fradkin P et al. | — | 2026 | → |
| Pathogenetic mechanisms of muscle-specific ribosomes in dilated cardiomyopathy. | Murphy MR et al. | — | 2026 | → |
| Plasma Proteome Signature for Leukocyte Telomere Length and Its Link to Abdominal Aortic Aneurysm. | Li A et al. | — | 2026 | → |
| Polygenic background contributes to GCK-MODY clinical presentation and glycaemic variability. | Murray Leech J et al. | — | 2026 | → |
| Polygenic risk and rare variants in endotypes of idiopathic pulmonary fibrosis: a genetic analysis of population-based and case-control cohorts. | Duckworth A et al. | — | 2026 | → |
| Polygenic risk scores and HLA class II variants are biomarkers of corticosteroid response in childhood nephrotic syndrome. | Tu T et al. | — | 2026 | → |
| Polymorphisms in intron 1 of HLA-DRA differentially associate with type 1 diabetes and celiac disease and implicate involvement of complement system genes C4A and C4B. | Aydemir O et al. | — | 2026 | → |
| Population Prevalence, Penetrance, and Mortality for Genetically Confirmed MODY. | Sharp LN et al. | — | 2026 | → |
| Postoperative Ileum Transcriptomics Implicate Sex-Biased Mechanisms in Crohn's Disease Recurrence. | Gettler K et al. | — | 2026 | → |
| Proteomic polygenic risk scores of age-related plasma protein levels reveal a role for Metalloproteinase inhibitor 2 (TIMP2) in cognitive performance. | Anastasi F et al. | — | 2026 | → |
| Proteomic risk score for early prediction of kidney disease progression in individuals with APOL1 high-risk genotypes. | Li C et al. | — | 2026 | → |
| Scalable and accurate rare-variant association tests for whole genome sequencing time-to-event analysis in large biobanks. | Song S et al. | — | 2026 | → |
| SDrecall: a sensitive approach for variant detection in segmental duplications. | Yang XT et al. | — | 2026 | → |
| The 1000 Chinese Pangenome empowers medical and population genetics. | Wang Y et al. | — | 2026 | → |
| The Age at Onset of LRRK2 p.Gly2019Ser Parkinson's Disease Across Ancestries and Countries of Origin. | Lüth T et al. | — | 2026 | → |
| The DNA virome varies with human genes and environments. | Kamitaki N et al. | — | 2026 | → |
| The IGVF catalog-from genetic variation to function. | Li D et al. | — | 2026 | → |
| The regulation, function and disease relevance of cytoplasmic tRNAs. | Stanley RE et al. | — | 2026 | → |
| Together, Shaping the Future: Our Collective Journey in Omics, Integrative Biology, AI, and the Future of Medicine. | Lin B | — | 2026 | → |
| Tutorial for variant interrogation in tumor samples. | Arseneau RJ et al. | — | 2026 | → |
| Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression. | Triolo TM et al. | — | 2026 | → |
| Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses. | Han Y et al. | — | 2026 | → |
| Unraveling Novel Genetic Determinants of Thiopurine Response Via TWAS. | Bidoli C et al. | — | 2026 | → |
| Voltage-Gated Sodium Channel Na<sub>V</sub>1.2: Structural Perspective of the Genetic Variability. | Oliveira-Madureira T et al. | — | 2026 | → |
| Whole Genome Sequence Analysis of Weight Loss in 16 972 Participants With COPD Reveals Novel Risk Loci in DRAIC and RFX3. | Chiles JW et al. | — | 2026 | → |
| Whole-genome sequence-based association analysis of African American individuals with bipolar disorder and schizophrenia. | Li R et al. | — | 2026 | → |
| Whole genome sequencing analysis of over 3500 individuals dementia-free over 85 years old. | Peloso GM et al. | — | 2026 | → |
| 50,000 years of evolutionary history of India: Impact on health and disease variation. | Kerdoncuff E et al. | — | 2025 | → |
| A benchmark study of compression software for human short-read sequence data. | Betschart RO et al. | — | 2025 | → |
| A calcium-sensing receptor allelic series and underdiagnosis of genetically driven hypocalcemia. | Chang JB et al. | — | 2025 | → |
| Accelerate the discovery of genetic variants in mitochondrial diseases with Variant prIOritization using Latent spAce. | Labory J et al. | — | 2025 | → |
| A common neural signature between genetic and environmental risk for mental illness. | Vedechkina M et al. | — | 2025 | → |
| A comparative review of short genetic variant databases across humans and animal species. | Van Buren SL et al. | — | 2025 | → |
| A comparison of genome-wide association analyses of persistent symptoms after Lyme disease, fibromyalgia, and myalgic encephalomyelitis - chronic fatigue syndrome. | Hirsch AG et al. | — | 2025 | → |
| A genome-wide association study of European advanced cancer patients treated with opioids identifies regulatory variants on chromosome 20 associated with pain intensity. | Minnai F et al. | — | 2025 | → |
| Aggregating single nucleotide polymorphisms improves filtering for false-positive associations postimputation. | Stahl K et al. | — | 2025 | → |
| A low-coverage skim-sequencing and imputation pipeline for genomic selection. | Sthapit SR et al. | — | 2025 | → |
| Alzheimer's disease genetic risk: Top African American risk allele frequencies and genetic architecture among Mexican-, African-, and non-Hispanic White Americans. | Housini M et al. | — | 2025 | → |
| Alzheimer's disease multi-ancestry genome-wide interaction and stratified study with smoking. | Dacey R et al. | — | 2025 | → |
| Analysis of Genome-Wide Association Studies. | Gampawar P et al. | — | 2025 | → |
| Analysis of left ventricular mass for African American individuals using multi-ancestry polygenic risk scores: the Jackson Heart Study. | McLaurin D et al. | — | 2025 | → |
| Analyzing the large and complex SFARI autism cohort data using the Genotypes and Phenotypes in Families (GPF) platform. | Chorbadjiev L et al. | — | 2025 | → |
| Ancestry gaps in cardiovascular GWAS: a multi-database review of African representation in genomic studies. | Pomales-Matos DA et al. | — | 2025 | → |
| An effective encoding of human medical conditions in disease space provides a versatile framework for deciphering disease associations. | Xu T et al. | — | 2025 | → |
| A novel approach to resilience and its links with education and Alzheimer's disease genetics. | Carrigan M et al. | — | 2025 | → |
| A Novel Frameshift Variant in the SPAST Gene Causing Hereditary Spastic Paraplegia in a Bulgarian-Turkish Family. | Levkova M et al. | — | 2025 | → |
| Antecedent Flu-Like Illness and Onset of Idiopathic Dilated Cardiomyopathy: The DCM Precision Medicine Study. | Ni H et al. | — | 2025 | → |
| Antipsychotic use in bipolar disorder: clinical and genomic correlates- a Mayo clinic bipolar disorder biobank study. | Singh B et al. | — | 2025 | → |
| APOE and Alzheimer's disease and related dementias risk among 12,221 Hispanics/Latinos. | Barral S et al. | — | 2025 | → |
| APOE p.(Leu167del) variant in hypercholesterolemia: Prevalence & phenotypic expression. | Bello-Álvarez D et al. | — | 2025 | → |
| A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate Cancer. | Farazi M et al. | — | 2025 | → |
| A positive ReceptivaDx result for BCL6 does not correlate with abnormal ERA results or decreased expression of receptivity-associated markers: two sides of the endometrial receptivity coin in fertility evaluation and treatment. | Huang D et al. | — | 2025 | → |
| Applying AI/ML for Analyzing Gene Expression Patterns. | Ahmed Z | — | 2025 | → |
| A replication study of novel fetal hemoglobin-associated genetic variants in sickle cell disease-only cohorts. | Ilboudo Y et al. | — | 2025 | → |
| A Spanish-Portuguese GWAS of progressive supranuclear palsy reveals a novel risk locus in NFASC. | García-González P et al. | — | 2025 | → |
| A specialized reference panel with structural variants integration for improving genotype imputation in Alzheimer disease and related dementias. | Cheng PL et al. | — | 2025 | → |
| Association analysis of indel variants and gene expression identifies MDM4 as a novel locus for skeletal muscle hypertrophy and power athlete status. | Kazan HH et al. | — | 2025 | → |
| Association of Epigenetic Age Acceleration and Mitochondrial DNA-Based Aging Metrics Provides Insights Into Mechanisms of Aging-Related Diseases. | Wang M et al. | — | 2025 | → |
| Association of Genetically Predicted Skipping of COL4A4 Exon 27 with Hematuria and Albuminuria. | Lona-Durazo F et al. | — | 2025 | → |
| Association of Genetic Predisposition to Inflammation With Cancer-Related Cognitive Impairment and Fatigue in Women Who Received Chemotherapy for Nonmetastatic Breast Cancer. | Olowofela AS et al. | — | 2025 | → |
| Association of genetic scores related to insulin resistance with neurological outcomes in ancestrally diverse cohorts from the Trans-Omics for Precision Medicine (TOPMed) program. | Sarnowski C et al. | — | 2025 | → |
| Association of Pathogenic/Likely Pathogenic Inherited Cardiomyopathy Variants With Heart Failure: A TOPMed Multiancestry Analysis. | Shetty NS et al. | — | 2025 | → |
| Association of SULT2A1 Locus With Abiraterone Clearance in the Alliance A031201: Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer. | Norton N et al. | — | 2025 | → |
| Associations of a multidimensional polygenic sleep health score and a sleep lifestyle index with disease outcomes and their interaction in a clinical biobank. | Paz V et al. | — | 2025 | → |
| Associations of Longitudinal Changes in Blood Biomarkers of Dementia With the Proportion of Genetically Inferred African Ancestry. | Wang L et al. | — | 2025 | → |
| Associations of plasma protein levels with risk of colorectal cancer: a proteome-wide Mendelian randomization study. | Pan ZK et al. | — | 2025 | → |
| A statistical framework for multi-trait rare variant analysis in large-scale whole-genome sequencing studies. | Li X et al. | — | 2025 | → |
| Astrocyte Reactivity Polygenic Risk Score May Predict Cognitive Decline in Alzheimer's Disease. | Phillips JM et al. | — | 2025 | → |
| A structurally informed human protein-protein interactome reveals proteome-wide perturbations caused by disease mutations. | Xiong D et al. | — | 2025 | → |
| Benchmarking and optimization of methods for the detection of identity-by-descent in high-recombining <i>Plasmodium falciparum</i> genomes. | Guo B et al. | — | 2025 | → |
| Benchmarking for genotyping and imputation using degraded DNA for forensic applications across diverse populations. | Zavala EI et al. | — | 2025 | → |
| Benchmarking Imputed Low Coverage Genomes in a Human Population Genetics Context. | Purnomo GA et al. | — | 2025 | → |
| Beyond blood flow: the multifaceted role of AMPK in regulating fetal growth at high altitudes. | Julian CG | — | 2025 | → |
| Beyond single references: pangenome graphs and the future of genomic medicine. | Nyaga DM et al. | — | 2025 | → |
| Bioinformatic insights into five Chinese population substructures inferred from the East Asian-specific AISNP panel. | Chen J et al. | — | 2025 | → |
| Bioinformatics and omics data management in genetic diagnosis. | Del Pozo A | — | 2025 | → |
| Blood Pressure and Mortality in Mexico City: A Mendelian Randomization Study. | Turner M et al. | — | 2025 | → |
| Bottlenecks in advancing and applying multiomic data integration-common data resources as rate-limiting drivers-the high-impact use case of atherosclerotic cardiovascular disease. | Bezzina Wettinger S et al. | — | 2025 | → |
| CADET: Enhanced transcriptome-wide association analyses in admixed samples using eQTL summary data. | Head ST et al. | — | 2025 | → |
| Calculating maternal polygenic risk scores from prenatal screening by cell-free DNA data. | Corey V et al. | — | 2025 | → |
| Calibrating genome wide significance by minor allele frequency across three major populations. | Vejandla SC et al. | — | 2025 | → |
| Canine genome-wide association study identifies <i>DENND1B</i> as an obesity gene in dogs and humans. | Wallis NJ et al. | — | 2025 | → |
| CAUSALdb2: an updated database for causal variants of complex traits. | Wang J et al. | — | 2025 | → |
| Cell-free DNA as a potential alternative to genomic DNA in genetic studies. | Zeng J et al. | — | 2025 | → |
| Cell-free DNA from clinical testing as a resource of population genetic analysis. | Zhu H et al. | — | 2025 | → |
| Cellular and Molecular Mechanisms of Innate Memory Responses. | Mhlanga MM et al. | — | 2025 | → |
| Characterization of the complex TB pharmacogenomic landscape in Africa using bioinformatic tools. | Oelofse C et al. | — | 2025 | → |
| Characterizing features affecting local ancestry inference performance in admixed populations. | Honorato-Mauer J et al. | — | 2025 | → |
| Cohort profile: the CORDELIA study (Collaborative cOhorts Reassembled Data to study mEchanisms and Longterm Incidence of chronic diseAses). | Hernáez Á et al. | — | 2025 | → |
| Combating Genetic Heterogeneity for Polygenic Prediction of Susceptibility to Brain β-Amyloid Deposition: Beyond <i>APOE</i>. | Ramanan VK et al. | — | 2025 | → |
| Common genetic variants modify disease risk and clinical presentation in monogenic diabetes. | Murray Leech J et al. | — | 2025 | → |
| Comprehensive assessment of the causal effects and metabolite mediators of glucose-lowering drug targets on cardio-renal-liver-metabolic health. | Huang H et al. | — | 2025 | → |
| Comprehensive genotypic, phenotypic, and biochemical characterization of GOT2 deficiency: A progressive neurodevelopmental disorder with epilepsy and abnormal movements. | German HM et al. | — | 2025 | → |
| Comprehensive mutational characterization of the calcium-sensing STIM1 EF-hand reveals residues essential for structure and function. | Kamath ND et al. | — | 2025 | → |
| Concentration and genetic regulation of sex hormone binding globulin and fracture risk in older women. | Wang Y et al. | — | 2025 | → |
| Congenital Anomalies in a Neonate With Partial Monosomy of Chromosome 21 q Arm: A Case Report. | Joy P et al. | — | 2025 | → |
| Contribution of genetics to hematopoietic stem cell mobilization: a genome-wide association study of 564 healthy donors mobilized with granulocyte colony-stimulating factor. | Stenzinger M et al. | — | 2025 | → |
| Correlates and consequences of clonal hematopoiesis expansion rate: a 16-year longitudinal study of 6976 women. | Pershad Y et al. | — | 2025 | → |
| Creating the Slovenian genome database and browser as a source of comprehensive variation of the Slovenian population. | Maver A et al. | — | 2025 | → |
| Cross-ancestral GWAS identifies 29 variants across head and neck cancer subsites. | Ebrahimi E et al. | — | 2025 | → |
| Cross-sectional, interventional, and causal investigation of insulin sensitivity using plasma proteomics in diverse populations. | Kho PF et al. | — | 2025 | → |
| Curation and validation of electronic medical record-based dementia diagnoses in the VA Million Veteran Program. | Merritt VC et al. | — | 2025 | → |
| Data sharing in the PRIMED Consortium: Design, implementation, and recommendations for future policymaking. | Smith JL et al. | — | 2025 | → |
| Deciphering the digenic architecture of congenital heart disease using trio exome sequencing data. | Kars ME et al. | — | 2025 | → |
| Decoding a Million Genomes: Unveiling the Protein-coding Landscape and Its Implications for Precision Medicine. | Zhang J | — | 2025 | → |
| Deep analysis of the major histocompatibility complex genetic associations using covariate analysis and haploblocks unravels new mechanisms for the molecular etiology of Elite Control in AIDS. | Rahmouni M et al. | — | 2025 | → |
| Deleterious mitochondrial heteroplasmies exhibit increased longitudinal change in variant allele fraction. | Kuiper LM et al. | — | 2025 | → |
| Description and first insights on a large genomic biobank of lung transplantation. | Brocard S et al. | — | 2025 | → |
| Development and recalibration of a multivariable type 1 diabetes prediction model for type 1 diabetes across multiple screening studies. | Templeman EL et al. | — | 2025 | → |
| Development and Validation of Polygenic Scores for Retinal Vessel Calibers. | Yu C et al. | — | 2025 | → |
| Diabetes Genetic Clusters and Clinical Outcomes in American Indians. | Reynolds KM et al. | — | 2025 | → |
| Differential performance of polygenic risk scores for heart disease in Hispanic/Latino subgroups: Findings of the Hispanic Community Health Study/Study of Latinos. | Hutten CG et al. | — | 2025 | → |
| Differential Performance of Polygenic Score for Coronary Artery Disease Based on Coronary Artery Calcium Between Men Living With and Without HIV. | Wojcik G et al. | — | 2025 | → |
| Differentiating the demographic histories and local adaptations of middle-altitude Qiang and Tibetan people. | Sun Q et al. | — | 2025 | → |
| Directional Selection and Evolution of Polygenic Traits in Eastern Eurasia: Insights from Ancient DNA. | Piffer D | — | 2025 | → |
| Disease-modifying effects of TMEM106B in genetic frontotemporal dementia: a longitudinal GENFI study. | Mirza SS et al. | — | 2025 | → |
| Diversifying Psychiatric Genomics: Globally Inclusive Strategies Toward Health Equity. | Giusti-Rodríguez P et al. | — | 2025 | → |
| Diversity and consequences of structural variation in the human genome. | Collins RL et al. | — | 2025 | → |
| Diversity and longitudinal records: Genetic architecture of disease associations and polygenic risk in the Taiwanese Han population. | Liu TY et al. | — | 2025 | → |
| DNA methylation markers of insulin resistance surrogate measures in the Atherosclerosis Risk in Communities (ARIC) study. | Shin J et al. | — | 2025 | → |
| DRP-PSM: Multi-Level Feature Integration Reveals Hierarchical Contributions to Pathogenic Synonymous Mutation Prediction. | Cai J et al. | — | 2025 | → |
| Early lipid genetics: identification of common and rare genetic variants for lipid traits in Indian adolescents. | Nair JM et al. | — | 2025 | → |
| Editorial: Advancements and prospects of genome-wide association studies. | Doumatey AP et al. | — | 2025 | → |
| Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results From the ODYSSEY OUTCOMES Trial. | Geba GP et al. | — | 2025 | → |
| Egypt Genome: Towards an African new genomic era. | Amer K et al. | — | 2025 | → |
| Elevated uric acid levels, mortality and cognitive impairment in children with severe malaria. | Bond C et al. | — | 2025 | → |
| Endometriosis and Ovarian Cancer: Insights from NHANES and Mendelian Randomization Analysis. | Liu D et al. | — | 2025 | → |
| Epidemiology and genetic determination of measures of peripheral vascular health in the Long Life Family Study. | Fricke DR et al. | — | 2025 | → |
| Epigenome-wide association study of incident type 2 diabetes in Black and White participants from the Atherosclerosis Risk in Communities Study. | Venkataraghavan S et al. | — | 2025 | → |
| Epigenome-wide association study of nuclear DNA methylation in relation to mitochondrial heteroplasmy. | Lai M et al. | — | 2025 | → |
| Epigenome-wide DNA methylation association study of CHIP provides insight into perturbed gene regulation. | Kirmani S et al. | — | 2025 | → |
| Estimating gene conversion rates from population data using multi-individual identity by descent. | Browning SR et al. | — | 2025 | → |
| Estimation of <i>PEX1</i>-mediated Zellweger spectrum disorder births and population prevalence by population genetics modeling. | Malone KE et al. | — | 2025 | → |
| European and African ancestry-specific plasma protein-QTL and metabolite-QTL analyses identify ancestry-specific T2D effector proteins and metabolites. | Yang C et al. | — | 2025 | → |
| Evaluating Practical Approaches for Including MYOC Variants Alongside Common Variants for Genetics-Based Risk Stratification for Glaucoma. | Le NQ et al. | — | 2025 | → |
| Evaluation of imputation performance of multiple reference panels in a Pakistani population. | Xu J et al. | — | 2025 | → |
| Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage. | Huang X et al. | — | 2025 | → |
| Expanding biobank pharmacogenomics through machine learning calls of structural variation. | Vanderwerff B et al. | — | 2025 | → |
| Exploration of Genetic Liability to Insomnia and Substance Use Disorders in Patients With Bipolar Disorder. | Melhuish Beaupre LM et al. | — | 2025 | → |
| Exploring depression treatment response by using polygenic risk scoring across diverse populations. | Lapinska S et al. | — | 2025 | → |
| Exploring the relationship between melanopsin gene variants, sleep, and markers of brain health. | Milligan Armstrong A et al. | — | 2025 | → |
| Externalizing as a common genetic influence for a broad spectrum of substance use and behavioral conditions: A developmental perspective from the Avon Longitudinal Study of Parents and Children. | Deng WQ et al. | — | 2025 | → |
| Fast and Memory-Efficient Dynamic Programming Approach for Large-Scale EHH-Based Selection Scans. | Rahman A et al. | — | 2025 | → |
| FDPSM: Feature-Driven Prediction Modeling of Pathogenic Synonymous Mutations. | Jin F et al. | — | 2025 | → |
| Fine-mapping the CYP2A6 regional association with nicotine metabolism among African American smokers. | Pouget JG et al. | — | 2025 | → |
| FLT1 and other candidate fetal haemoglobin modifying loci in sickle cell disease in African ancestries. | Wonkam A et al. | — | 2025 | → |
| Folate Interaction With Genetic Risk for Neural Tube Defects Among Infants in Bangladesh. | Mondragon-Estrada E et al. | — | 2025 | → |
| GDBIG: A Pioneering Birth Cohort Genomic Platform Facilitating Intergenerational Genetic Research. | Huang S et al. | — | 2025 | → |
| Gene-Air Pollution Interaction and Diversity of Genetic Sampling: The Southern California Children's Health Study. | Po J et al. | — | 2025 | → |
| General Kernel Machine Methods for Multi-Omics Integration and Genome-Wide Association Testing With Related Individuals. | Little A et al. | — | 2025 | → |
| Generation of prostate cancer assembloids modeling the patient-specific tumor microenvironment. | Lee J et al. | — | 2025 | → |
| Gene regulatory activity associated with polycystic ovary syndrome revealed DENND1A-dependent testosterone production. | Sankaranarayanan L et al. | — | 2025 | → |
| Gene-Smoking Interaction in Insulin Sensitivity and β-Cell Function Among Normal Glucose Tolerance Individuals. | Gu P et al. | — | 2025 | → |
| Genetic analysis in African ancestry populations reveals genetic contributors to lung cancer susceptibility. | Betti MJ et al. | — | 2025 | → |
| Genetic and Genomic Testing in Cardiovascular Disease: A Policy Statement From the American Heart Association. | Landstrom AP et al. | — | 2025 | → |
| Genetic architecture and analysis practices of circulating metabolites in the NHLBI Trans-Omics for Precision Medicine Program. | Wang N et al. | — | 2025 | → |
| Genetic Architecture of Idiopathic Inflammatory Myopathies From Meta-Analyses. | Zhu C et al. | — | 2025 | → |
| Genetic Associations With C-peptide Levels Before Type 1 Diabetes Diagnosis in At-risk Relatives. | Triolo TM et al. | — | 2025 | → |
| Genetic determinants and genomic consequences of non-leukemogenic somatic point mutations. | Weinstock JS et al. | — | 2025 | → |
| Genetic Discovery and Risk Prediction for Type 1 Diabetes in Individuals Without High-Risk HLA-DR3/DR4 Haplotypes. | McGrail C et al. | — | 2025 | → |
| Genetic effects on chromatin accessibility uncover mechanisms of liver gene regulation and quantitative traits. | Currin KW et al. | — | 2025 | → |
| Genetic heterogeneity and homogeneity among orofacial cleft subtypes: genome-wide association studies in the cleft collective. | Dack K et al. | — | 2025 | → |
| Genetic insights into cardiac conduction disorders from genome-wide association studies. | Li B et al. | — | 2025 | → |
| Genetic insights into CRP levels in Indian adolescents: confirming adult genetic associations. | Nair JM et al. | — | 2025 | → |
| Genetic overlap between functional impairment and depression and anxiety symptom severity: evidence from the GLAD Study. | Skelton M et al. | — | 2025 | → |
| Genetic regulation of TERT splicing affects cancer risk by altering cellular longevity and replicative potential. | Florez-Vargas O et al. | — | 2025 | → |
| Genetic Risk and OCT-Based Phenotypic Associations in Age-Related Macular Degeneration. | Jaskoll S et al. | — | 2025 | → |
| Genetics and context for precision health in Greater Boston. | Koyama S et al. | — | 2025 | → |
| Genetics of C-Peptide and Age at Diagnosis in Type 1 Diabetes. | Roshandel D et al. | — | 2025 | → |
| Genetics of Familial Hemophagocytic Lymphohistiocytosis (HLH). | Zhang K et al. | — | 2025 | → |
| Genetic study of von Willebrand factor antigen levels ≤ 50 IU/dL identifies variants associated with increased risk of von Willebrand disease and bleeding. | Friedman RK et al. | — | 2025 | → |
| Genetic susceptibility and validation of angiographic patterns in Takayasu arteritis. | Casares-Marfil D et al. | — | 2025 | → |
| Genetic Testing in Periodontitis: A Narrative Review on Current Applications, Limitations, and Future Perspectives. | Modafferi C et al. | — | 2025 | → |
| Genetic testing of common and rare variants in dementia patients from a memory clinic : Dementia-related genetic testing in memory clinic. | de Rojas I et al. | — | 2025 | → |
| Genetic Variants Associated With Preeclampsia and Maternal Serum sFLT1 Levels. | Mack JA et al. | — | 2025 | → |
| Genetic Variants, Metabolic Dysfunction-Associated Fatty Liver Disease, and Major Health Outcomes in Older Adults. | Clayton-Chubb D et al. | — | 2025 | → |
| Genetic variation in RYR1 is associated with heart failure progression and mortality in a diverse patient population. | Guerra LA et al. | — | 2025 | → |
| Genome diversity and signatures of natural selection in mainland Southeast Asia. | He Y et al. | — | 2025 | → |
| Genome-to-genome analysis reveals associations between human and mycobacterial genetic variation in tuberculosis patients from Tanzania. | Xu ZM et al. | — | 2025 | → |
| Genome-wide allele-specific expression in multi-tissue samples from healthy male baboons reveals the transcriptional complexity of mammals. | Ramasamy R et al. | — | 2025 | → |
| Genome-wide association analyses identify candidate loci for amyloid imaging and plasma biomarkers in adults with Down syndrome. | Aslam MM et al. | — | 2025 | → |
| Genome-wide association meta-analysis of human olfactory identification discovers sex-specific and sex-differential genetic variants. | Förster F et al. | — | 2025 | → |
| Genome-wide association of tau neuroimaging and plasma biomarkers in adults with Down syndrome. | Fan KH et al. | — | 2025 | → |
| Genome-wide association studies of TDP-43 proteinopathy and hippocampal sclerosis reveal shared genetic associations with APOE and TMEM106B. | Godrich D et al. | — | 2025 | → |
| Genome-wide association study meta-analysis uncovers novel genetic variants associated with olfactory dysfunction. | Imtiaz MA et al. | — | 2025 | → |
| Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer. | Barnes DR et al. | — | 2025 | → |
| Genome-wide association study of childhood B-cell acute lymphoblastic leukemia reveals novel African ancestry-specific susceptibility loci. | Im C et al. | — | 2025 | → |
| Genome-wide association study of early-stage non-small cell lung cancer prognosis: a pooled analysis in the International Lung Cancer Consortium. | Dong M et al. | — | 2025 | → |
| Genome-wide association study of myocarditis and pericarditis following COVID-19 vaccination. | Cavalli M et al. | — | 2025 | → |
| Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves prediction across ancestry groups. | Hoffmann TJ et al. | — | 2025 | → |
| Genome-wide meta-analysis associates donor-recipient non-HLA genetic mismatch with acute cellular rejection post-liver transplantation. | Nieuwenhuis LM et al. | — | 2025 | → |
| Genome-wide pleiotropy analysis of longitudinal blood pressure and harmonized cognitive performance measures. | Kang M et al. | — | 2025 | → |
| Genome-wide study links cardiometabolic factors to cognition via APOA4-APOA5-ZPR1-BUD13 and other loci in rural Indians. | Chakraborty S et al. | — | 2025 | → |
| Genomic analysis of 11,555 probands identifies 60 dominant congenital heart disease genes. | Sierant MC et al. | — | 2025 | → |
| Genomic and phenotypic correlates of mosaic loss of chromosome Y in blood. | Jakubek YA et al. | — | 2025 | → |
| Genomic and Serological Rheumatoid Arthritis Biomarkers, <i>MUC5B</i> Promoter Variant, and Interstitial Lung Abnormalities. | Kim JS et al. | — | 2025 | → |
| Genomic Anomaly Detection with Functional Data Analysis. | Kanjilal R et al. | — | 2025 | → |
| Genomic profiling of circulating tumor DNA for childhood cancers. | Lei S et al. | — | 2025 | → |
| Genomic risk prediction for depression in a large prospective study of older adults of European descent. | Yu C et al. | — | 2025 | → |
| Genomic risk prediction for type 2 diabetes in Australian individuals aged 70 years and older. | Yu C et al. | — | 2025 | → |
| Genomic Risk Prediction of Incident Atrial Fibrillation in Older Individuals Without Prior Cardiovascular Disease. | Fransquet PD et al. | — | 2025 | → |
| Germline determinants of toxicity and efficacy in patients with large B-cell lymphoma treated with CAR T-cell therapy. | Strati P et al. | — | 2025 | → |
| Global and Sex-Stratified Genome-Wide Association Study of Long COVID Based on Patient-Driven Symptom Recall. | Polo-Alonso S et al. | — | 2025 | → |
| GWAS for Defining the Pathogenesis of Hypertension: Have They Delivered? | Alexander MR et al. | — | 2025 | → |
| GWAS for primary angle-closure glaucoma identifies loci related to ocular biometry and morphology. | Luben RN et al. | — | 2025 | → |
| Haemochromatosis Genotypes and Incident Dementia in a Prospective Study of Older Adults. | Yu C et al. | — | 2025 | → |
| High-fidelity and differential nonsense suppression in live cells and a frontotemporal dementia allele with human transfer RNAs. | Beharry A et al. | — | 2025 | → |
| How does gut microbiota affect the vaginitis axis? The mediating role of plasma metabolites. | Li M et al. | — | 2025 | → |
| How Everything Is Connected to Everything Else - Population-Specific Connections between Adaptive Evolution, Disease Susceptibility, and Drug Responsiveness. | Tang J et al. | — | 2025 | → |
| Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestry. | Schuermans A et al. | — | 2025 | → |
| Human genetic variation reveals FCRL3 is a lymphocyte receptor for Yersinia pestis. | Keener RM et al. | — | 2025 | → |
| Human plasma proteomic profile of clonal hematopoiesis. | Yu Z et al. | — | 2025 | → |
| IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes. | Sims EK et al. | — | 2025 | → |
| Identification of recurrent <i>MYH7</i> variant hypertrophic cardiomyopathy patients in Korea: a case series. | Ryu SW et al. | — | 2025 | → |
| Identifying associations of de novo noncoding variants with autism through integration of gene expression, sequence, and sex information. | Li R et al. | — | 2025 | → |
| Identifying individuals with rare disease variants by inferring shared ancestral haplotypes from SNP array data. | Robertson E et al. | — | 2025 | → |
| Impact of rare non-coding variants on human diseases through alternative polyadenylation outliers. | Zou X et al. | — | 2025 | → |
| Improved multiancestry fine-mapping identifies cis-regulatory variants underlying molecular traits and disease risk. | Lu Z et al. | — | 2025 | → |
| Imputation disparities driven by recent selection and their impact on disease risk estimation in East and Southeast Asian populations. | Li D et al. | — | 2025 | → |
| Increased risk of chronic diseases and multimorbidity in middle-aged and elderly individuals with early vision, hearing, or dual sensory impairments: insights from prospective cohort studies and Mendelian randomization analysis. | Wang Y et al. | — | 2025 | → |
| Independent versus joint effects of polygenic or family-based schizophrenia risk in diverse ancestry youth in the ABCD study. | Hyat M et al. | — | 2025 | → |
| Inefficient maturation of disease-linked mutant forms of the KCC2 potassium-chloride cotransporter correlates with predicted pathogenicity. | Kok M et al. | — | 2025 | → |
| Insights into ancestral diversity in Parkinson's disease risk: a comparative assessment of polygenic risk scores. | Saffie-Awad P et al. | — | 2025 | → |
| Insights into pharmacogenetics, drug-gene interactions, and drug-drug-gene interactions. | Russell LE et al. | — | 2025 | → |
| Integrated genetic and geographic ancestry prediction via large-scale genomic data and machine learning. | Chen J et al. | — | 2025 | → |
| Integrated single-cell multiomic profiling of caudate nucleus suggests key mechanisms in alcohol use disorder. | Green NC et al. | — | 2025 | → |
| Integration of GWAS, QTLs and keratinocyte functional assays reveals molecular mechanisms of atopic dermatitis. | Oliva M et al. | — | 2025 | → |
| Interactions of genes with alcohol consumption affect insulin sensitivity and beta cell function. | Fu Q et al. | — | 2025 | → |
| Interpreting mammalian synonymous site conservation in light of the unwanted transcript hypothesis. | Christmas MJ et al. | — | 2025 | → |
| Intronic branchpoint-to-acceptor variants underlying inborn errors of immunity. | Alioua N et al. | — | 2025 | → |
| In Utero Exposure to Maternal Hyperglycemia and Offspring Type 2 Diabetes Genetic Risk Score Are Independently Associated With Risk of Impaired Glucose Tolerance in Youth. | Dieguez AC et al. | — | 2025 | → |
| Investigating the interplay between prematurity and genetic variation in the context of rare developmental disorders. | Wootton O et al. | — | 2025 | → |
| Joint, multifaceted genomic analysis enables diagnosis of diverse, ultra-rare monogenic presentations. | Kobren SN et al. | — | 2025 | → |
| Large-scale GWAS of strabismus identifies risk loci and provides support for a link with maternal smoking. | He W et al. | — | 2025 | → |
| Large-scale transcriptomic analyses of major depressive disorder reveal convergent dysregulation of synaptic pathways in excitatory neurons. | Goes FS et al. | — | 2025 | → |
| Leveraging local ancestry and cross-ancestry genetic architecture to improve genetic prediction of complex traits in admixed populations. | Zhou G et al. | — | 2025 | → |
| Life Purpose Lowers Risk for Cognitive Impairment in a United States Population-Based Cohort. | Howard NC et al. | — | 2025 | → |
| Linking epidemiology and genomics of maternal smoking during pregnancy in utero and in ageing: a population-based study using human foetuses and the UK Biobank cohort. | Mihov M et al. | — | 2025 | → |
| Linking polygenic risk scores to dopaminergic neuron loss using neuromelanin-sensitive imaging. | Lanore A et al. | — | 2025 | → |
| Logica: A likelihood framework for cross-ancestry local genetic correlation estimation using summary statistics. | Gao B et al. | — | 2025 | → |
| Longitudinal analysis of electronic health records reveals medical conditions associated with subsequent Alzheimer's disease development. | Zhong X et al. | — | 2025 | → |
| Machine learning models for pharmacogenomic variant effect predictions - recent developments and future frontiers. | Tremmel R et al. | — | 2025 | → |
| Mapping the landscape of childhood obesity: genomic insights and socioeconomic status in Indian school-going children. | Nair JM et al. | — | 2025 | → |
| Merging High-Throughput, Amplicon-Based Second and Third Generation Sequencing Data: An Integrative and Modular Data Analysis Framework for Haplotype Prediction and Output Evaluation. | Mink S et al. | — | 2025 | → |
| Meta-analysis reveals transcription factors and DNA binding domain variants associated with congenital heart defect and orofacial cleft. | Jeong R et al. | — | 2025 | → |
| Methods for multiancestry genome-wide association study meta-analysis. | Yap CF et al. | — | 2025 | → |
| Methylation profile of individuals with sickle cell trait. | Vasconcelos AG et al. | — | 2025 | → |
| Molecular and genetic insights into human ovarian aging from single-nuclei multi-omics analyses. | Jin C et al. | — | 2025 | → |
| Moroccan genome project: genomic insight into a North African population. | El Fahime E et al. | — | 2025 | → |
| MorPhiC Consortium: towards functional characterization of all human genes. | Adli M et al. | — | 2025 | → |
| Multi-ancestry genome-wide association analyses: a comparison of meta- and mega-analyses in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study. | Kuang A et al. | — | 2025 | → |
| Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer's disease. | Rajabli F et al. | — | 2025 | → |
| Multi-ancestry meta-analysis identifies genetic modifiers of age-at-onset of Alzheimer's disease at known and novel loci. | Blue EE et al. | — | 2025 | → |
| Multi-ancestry meta-analysis of keloids uncovers novel susceptibility loci in diverse populations. | Greene CA et al. | — | 2025 | → |
| Multi-ancestry sequencing-based genome-wide association study of C-reactive protein in 513,273 genomes. | Li H et al. | — | 2025 | → |
| Multi-ancestry whole genome sequencing analysis of lean body mass. | Zhang X et al. | — | 2025 | → |
| Multimodal data integration to predict atrial fibrillation. | Yao Y et al. | — | 2025 | → |
| Multi-omic derived cell-type specific Alzheimer disease polygenic risk scores. | O'Neill N et al. | — | 2025 | → |
| Multi-omics mediation pipeline reveals differential pathways of maternal SNPs affecting newborn adiposity outcomes. | Gill NP et al. | — | 2025 | → |
| Multiomics reveal key inflammatory drivers of severe obesity: IL4R, LILRA5, and OSM. | Chen HH et al. | — | 2025 | → |
| Multiparametric MRI along with machine learning predicts prognosis and treatment response in pediatric low-grade glioma. | Fathi Kazerooni A et al. | — | 2025 | → |
| Multiple-testing corrections in selection scans using identity-by-descent segments. | Temple SD et al. | — | 2025 | → |
| MultiSTAAR delivers multi-trait rare variant analysis of biobank-scale sequencing data. | — | — | 2025 | → |
| Mutational landscape of triple-negative breast cancer in African American women. | Yao S et al. | — | 2025 | → |
| Myeloid cell genome-wide screen identifies variants associated with Mycobacterium tuberculosis-induced cytokine transcriptional responses. | Ivie JJ et al. | — | 2025 | → |
| Natural human tRNA<sup>Ala</sup> anticodon variants mistranslate the genetic code. | Tennakoon R et al. | — | 2025 | → |
| Non-coding cis-regulatory variants in HK1 cause congenital hyperinsulinism with variable disease severity. | Bennett JJ et al. | — | 2025 | → |
| Noncoding rare variant associations with blood traits in 166,740 UK Biobank genomes. | Ribeiro DM et al. | — | 2025 | → |
| Non-genetic and genetic determinants of serum selenium and selenium species in the Aragon Workers Health Study. | Rodriguez-Hernandez Z et al. | — | 2025 | → |
| Novel Compound Heterozygous Mutations of LIG4 Gene in an Indian <i>LIG4</i> Syndrome Patient with Severe Microcephaly: Case Report, <i>In-silico</i> Analysis and Systematic Review. | Singh A et al. | — | 2025 | → |
| Novel genetic associations with childhood adipocytokines in Indian adolescents. | Nair JM et al. | — | 2025 | → |
| Novel modelling approaches to elucidate the genetic architecture of resilience to Alzheimer's disease. | Phillips JM et al. | — | 2025 | → |
| Novel risk loci encompassing genes influencing STAT3, GPCR, and oxidative stress signaling are associated with co-morbid GERD and COPD. | Wilson AC et al. | — | 2025 | → |
| Novel Viral Sequences in a Patient with Cryptogenic Liver Cirrhosis Revealed by Serum Virome Sequencing. | Zhang X et al. | — | 2025 | → |
| On the analysis of metabolite quantitative trait loci: Impact of different data transformations and study designs. | Lee S et al. | — | 2025 | → |
| Parent-of-origin effects in the life-course evolution of cardiometabolic traits. | Wagh R et al. | — | 2025 | → |
| PathwayVote: an R package for robust pathway enrichment analysis for DNA methylation data using a consensus-based voting framework. | Zheng Y et al. | — | 2025 | → |
| Perspectives and opportunities in forensic human, animal, and plant integrative genomics in the Pangenome era. | He G et al. | — | 2025 | → |
| Pharmacogenomics of the Etonogestrel Contraceptive Implant: A Genome-Wide Association Study of Steady-State Etonogestrel Concentrations. | Lazorwitz A et al. | — | 2025 | → |
| Pharmacogenomic Study of SARS-CoV-2 Treatments: Identifying Polymorphisms Associated with Treatment Response in COVID-19 Patients. | Serra-Llovich A et al. | — | 2025 | → |
| PIC-SURE: an open-source platform for integrating clinical and genomic data. | Gutiérrez-Sacristán A et al. | — | 2025 | → |
| Pilot work of the 10K Chinese People Genomic Diversity Project along the Silk Road suggests a complex east-west admixture landscape and biological adaptations. | He G et al. | — | 2025 | → |
| Plasma Glucosylceramide Levels Are Regulated by ATP10D and Are Not Involved in Parkinson's Disease Pathogenesis. | Somerville EN et al. | — | 2025 | → |
| Plasma proteins and onset of atherosclerosis: integrating human plasma proteogenomics, transcriptomics and in vivo evidence. | Chen K et al. | — | 2025 | → |
| Plasma pTau181 and amyloid markers predict conversion to dementia in idiopathic REM sleep behaviour disorder. | Delva A et al. | — | 2025 | → |
| Polygenic and developmental profiles of autism differ by age at diagnosis. | Zhang X et al. | — | 2025 | → |
| Polygenic associations with clinical and neuropathological trait heterogeneity across TDP-43 proteinopathies. | Spencer BE et al. | — | 2025 | → |
| Polygenic risk of idiopathic pulmonary fibrosis and COVID-19 severity. | Guillen-Guio B et al. | — | 2025 | → |
| Polygenic Risk Prediction for Normal-Tension Glaucoma. | Marzban M et al. | — | 2025 | → |
| Polygenic risk score for type 2 diabetes shows context-dependent effects across populations. | Guo B et al. | — | 2025 | → |
| Polygenic score analysis identifies distinct genetic risk profiles in Alzheimer's disease comorbidities. | Hernández CF et al. | — | 2025 | → |
| Polygenic scores contribution to Parkinson's disease comorbidities. | Hernández CF et al. | — | 2025 | → |
| Population-scale cross-disorder atlas of the human prefrontal cortex at single-cell resolution. | Fullard JF et al. | — | 2025 | → |
| Potential Causal Relationship Between Chronic Obstructive Pulmonary Disease and Diabetes: A Bidirectional Two-Sample Mendelian Randomization Study. | Wang X et al. | — | 2025 | → |
| Prediction of metabolic subphenotypes of type 2 diabetes via continuous glucose monitoring and machine learning. | Metwally AA et al. | — | 2025 | → |
| Predictive performance for alcohol use disorder of polygenic scores based on the general addiction risk factor and problematic alcohol use. | Pérez-Gutiérrez AM et al. | — | 2025 | → |
| PRED-LD: efficient imputation of GWAS summary statistics. | Manios GA et al. | — | 2025 | → |
| Prevalence of Actionable Pharmacogenetic Genotype Frequencies, Cautionary Medication Use, and Polypharmacy in Community-Dwelling Older Adults. | Bousman CA et al. | — | 2025 | → |
| Protein quantitative trait locus analysis in African American and non-Hispanic White individuals. | Cai Y et al. | — | 2025 | → |
| Proteome-wide association studies for blood lipids and comparison with transcriptome-wide association studies. | Zhang D et al. | — | 2025 | → |
| Proxy panels enable privacy-aware outsourcing of genotype imputation. | Zhi D et al. | — | 2025 | → |
| PTEN mutations impair CSF dynamics and cortical networks by dysregulating periventricular neural progenitors. | DeSpenza T et al. | — | 2025 | → |
| py_ped_sim: a flexible forward pedigree and genetic simulator for complex family pedigree analysis. | Guardado M et al. | — | 2025 | → |
| Quantifying the impact of early life growth adversity on later life health. | Goldman-Pham R et al. | — | 2025 | → |
| Rare damaging CCR2 variants are associated with lower lifetime cardiovascular risk. | Georgakis MK et al. | — | 2025 | → |
| Rare germline structural variants increase risk for pediatric solid tumors. | Gillani R et al. | — | 2025 | → |
| Rationale and Design of the HeartShare/AMP-HF Deep Phenotyping Study to Improve Understanding of Heart Failure With Preserved Ejection Fraction. | Borlaug BA et al. | — | 2025 | → |
| Real-time dynamic polygenic prediction for streaming data. | Tubbs JD et al. | — | 2025 | → |
| Recommendations for responsible use of population descriptors in polygenic risk score development. | Smith JL et al. | — | 2025 | → |
| Refining rare disease variant discovery in an isolated Andean community through imputation-enhanced IBD and kinship inference from whole exome sequencing data. | Gaviria-Sabogal CC et al. | — | 2025 | → |
| regionalpcs improve discovery of DNA methylation associations with complex traits. | Eulalio T et al. | — | 2025 | → |
| Regulatory QTLs affecting miRNA-mRNA interactions in cancer: mechanisms, methods, and clinical implications. | Kumar V et al. | — | 2025 | → |
| Researcher views on returning results from multi-omics data to research participants: insights from The Molecular Transducers of Physical Activity Consortium (MoTrPAC) Study. | Ormond KE et al. | — | 2025 | → |
| Risk of clonal hematopoiesis in families exposed to radiation following the Chornobyl accident. | Machiela MJ et al. | — | 2025 | → |
| [Role of genetics in precision medicine of coronary artery disease]. | Sanin V et al. | — | 2025 | → |
| Secure phasing of private genomes in a trusted execution environment with TX-Phase. | Dokmai N et al. | — | 2025 | → |
| Sequencing in over 50,000 cases identifies coding and structural variation underlying atrial fibrillation risk. | Choi SH et al. | — | 2025 | → |
| Serum IgA isotypes are associated with percent emphysema, wall thickness and lung function decline. | Pottinger T et al. | — | 2025 | → |
| Serum microRNA expression quantitative trait loci in children with asthma colocalize with asthma-related GWAS results. | Hecker J et al. | — | 2025 | → |
| Sex-specific spirometry effects of adult COPD polygenic score in children with asthma. | Kelchtermans J et al. | — | 2025 | → |
| Shared biological pathways linking ADHD and cortisol variability are related to externalizing behaviors. | Ramos JKN et al. | — | 2025 | → |
| Shared genetic susceptibility between idiopathic inflammatory myopathies and common B cell lymphoma subtypes found primarily in the human leucocyte antigen region. | Che WI et al. | — | 2025 | → |
| Single-cell analysis of cerebrospinal fluid reveals common features of neuroinflammation. | Jacobs BM et al. | — | 2025 | → |
| Small-RNA sequencing identifies serum microRNAs associated with abnormal electrocardiography findings in patients with Chagas disease. | Mueller M et al. | — | 2025 | → |
| SPAmix: a scalable, accurate, and universal analysis framework for large-scale genetic association studies in admixed populations. | Ma Y et al. | — | 2025 | → |
| SREBF1, a target gene of multiple sclerosis and coronary heart disease: based on mendelian randomization study. | Du L et al. | — | 2025 | → |
| STICI: Split-Transformer with integrated convolutions for genotype imputation. | Mowlaei ME et al. | — | 2025 | → |
| STRchive: a dynamic resource detailing population-level and locus-specific insights at tandem repeat disease loci. | Hiatt L et al. | — | 2025 | → |
| Streamlining large-scale genomic data management: Insights from the UK Biobank whole-genome sequencing data. | Li X et al. | — | 2025 | → |
| Structure of human MUTYH and functional profiling of cancer-associated variants reveal an allosteric network between its [4Fe-4S] cluster cofactor and active site required for DNA repair. | Trasviña-Arenas CH et al. | — | 2025 | → |
| Systematic analysis of nonsense variants uncovers peptide release rate as a novel modifier of nonsense-mediated mRNA decay. | Kolakada D et al. | — | 2025 | → |
| Systemic Sclerosis in Kazakh Patients: A Preliminary Case-Control Immunogenetic Profiling Study. | Zaripova L et al. | — | 2025 | → |
| Targeting specific kinase substrates rescues increased colitis severity induced by the Crohn's disease-linked LRRK2-N2081D variant. | Heaton GR et al. | — | 2025 | → |
| The breadth and impact of the Global Lipids Genetics Consortium. | Dron JS et al. | — | 2025 | → |
| The clinical and molecular landscape of breast cancer in women of African and South Asian ancestry. | Thorn GJ et al. | — | 2025 | → |
| The contribution of gametic phase disequilibrium to the heritability of complex traits. | Zhang Y et al. | — | 2025 | → |
| The distribution of highly deleterious variants across human ancestry groups. | Stolyarova A et al. | — | 2025 | → |
| The Eating Disorders Genetics Initiative 2 (EDGI2): study protocol. | Berthold N et al. | — | 2025 | → |
| The e-BRAVE study: A prospective web-based cohort and biobank of women carriers of BRCA mutations. | Oliverio A et al. | — | 2025 | → |
| The effect of Alzheimer's disease genetic factors on limbic white matter microstructure. | Lorenz A et al. | — | 2025 | → |
| The evolution of dbSNP: 25 years of impact in genomic research. | Phan L et al. | — | 2025 | → |
| The Great Genotyper: a graph-based method for population genotyping of small and structural variants. | Shokrof M et al. | — | 2025 | → |
| The human and non-human primate developmental GTEx projects. | Coorens THH et al. | — | 2025 | → |
| The Impact of Ancestry on Genome-Wide Association Studies. | Jones SC et al. | — | 2025 | → |
| The impact of imprecise case definitions in electronic health record research: a melanoma case-study from the Million Veteran Program. | Wheless L et al. | — | 2025 | → |
| The main mediating lipid species in cholesterol-induced colorectal cancer risk. | Wang Y et al. | — | 2025 | → |
| The neuronal chromatin landscape in brains from individuals with schizophrenia is linked to early fetal development. | Girdhar K et al. | — | 2025 | → |
| The pharmacogenomic landscape in the Chinese: An analytics of pharmacogenetic variants in 206,640 individuals. | Wang LY et al. | — | 2025 | → |
| The role of the hippocampus and SLC39A8 in chronic musculoskeletal pain-induced dementia: a Mendelian randomization study. | Du K et al. | — | 2025 | → |
| Toward Responsible and Sustainable Data Sharing in Large-scale Cohort-based Genomic Research. | Song 宋洁 J et al. | — | 2025 | → |
| Transcriptional impacts of substance use disorder and HIV on human ventral midbrain neurons and microglia. | Wilson AM et al. | — | 2025 | → |
| Trans-eQTL mapping prioritises USP18 as a negative regulator of interferon response at a lupus risk locus. | Freimann K et al. | — | 2025 | → |
| Trans-ethnic GWAS meta-analysis of idiopathic spermatogenic failure highlights the immune-mediated nature of Sertoli cell-only syndrome. | González-Muñoz S et al. | — | 2025 | → |
| Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations. | Nicolas A et al. | — | 2025 | → |
| Translating pharmacogenomic sequencing data into drug response predictions-How to interpret variants of unknown significance. | Tremmel R et al. | — | 2025 | → |
| TREM2 risk variants and associated endophenotypes in alzheimer's disease. | Dijkstra JIR et al. | — | 2025 | → |
| Tutorial: guidelines for quality filtering of whole-exome and whole-genome sequencing data for population-scale association analyses. | Sealock JM et al. | — | 2025 | → |
| Type 1 Diabetes Genetic Risk Contributes to Phenotypic Presentation in Monogenic Autoimmune Diabetes. | Luckett AM et al. | — | 2025 | → |
| Type 1 Diabetes Polygenic Scores Improve Diagnostic Accuracy in Pediatric Diabetes Care. | Kreienkamp RJ et al. | — | 2025 | → |
| Type 1 diabetes prediction in autoantibody-positive individuals: performance, time and money matter. | Ferrat LA et al. | — | 2025 | → |
| Type 2 diabetes polygenic risk score demonstrates context-dependent effects and associations with type 2 diabetes-related risk factors and complications across diverse populations | Guo B et al. | — | 2025 | — |
| UHRF2 as a genetic correlate of hospitalization in sickle cell disease. | Cintho Ozahata M et al. | — | 2025 | → |
| Unraveling immunity: insights from biobank-scale data. | Richardson A et al. | — | 2025 | → |
| Unraveling the genetics of gulf war illness in diverse participants enrolled in the million veteran program. | Pathak GA et al. | — | 2025 | → |
| Unravelling the genetic architecture of inflammatory bowel disease multiplex families with rare and common variant polygenic risk scores. | Jans DS et al. | — | 2025 | → |
| Unveiling the Genetic Landscape of Coronary Artery Disease Through Common and Rare Structural Variants. | Iyer KR et al. | — | 2025 | → |
| Urofacial (Ochoa) syndrome with a founder pathogenic variant in the HPSE2 gene: a case report and mutation origin. | Del Valle-Peréz M et al. | — | 2025 | → |
| Using Genomics to Develop Personalized Cardiovascular Treatments. | Sanghvi MM et al. | — | 2025 | → |
| Using the ancestral recombination graph to study the history of rare variants in founder populations. | Mejia-Garcia A et al. | — | 2025 | → |
| varCADD: large sets of standing genetic variation enable genome-wide pathogenicity prediction. | Nazaretyan L et al. | — | 2025 | → |
| Variant Classification Using Proteomics-Informed Large Language Models Increases Power of Rare Variant Association Studies and Enhances Target Discovery. | Gillies CE et al. | — | 2025 | → |
| Variants in CALD1, ESRP1, and RBFOX1 are associated with orofacial cleft risk. | Carlson JC et al. | — | 2025 | → |
| Variants in the β-globin locus are associated with pneumonia in African American children. | Halligan NLN et al. | — | 2025 | → |
| weIMPUTE: a user-friendly web-based genotype imputation platform. | Li M et al. | — | 2025 | → |
| Whole genome sequence analysis of low-density lipoprotein cholesterol across 246 K individuals. | Selvaraj MS et al. | — | 2025 | → |
| Whole-genome sequencing analysis identifies rare, large-effect noncoding variants and regulatory regions associated with circulating protein levels. | Hawkes G et al. | — | 2025 | → |
| Whole genome sequencing analysis of body mass index identifies novel African ancestry-specific risk allele. | Zhang X et al. | — | 2025 | → |
| Whole-genome Sequencing Association Analysis of Quantitative Platelet Traits in A Large Cohort of β-thalassemia. | Wang X et al. | — | 2025 | → |
| Widespread recessive effects on common diseases in a cohort of 44,000 British Pakistanis and Bangladeshis with high autozygosity. | Heng TH et al. | — | 2025 | → |
| X chromosome inactivation across primary human tissues is mostly complete, with significant implications for genetic and clinical studies. | Shriner D et al. | — | 2025 | → |
| X-chromosome-wide association study for Alzheimer's disease. | Le Borgne J et al. | — | 2025 | → |
| ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer's disease through BDNF/NGFR signaling. | Tayran H et al. | — | 2024 | → |
| A cell type-aware framework for nominating non-coding variants in Mendelian regulatory disorders. | Lee AS et al. | — | 2024 | → |
| A comprehensive genetic variant reference for the Chinese population. | Jiang T et al. | — | 2024 | → |
| A comprehensive study of common and rare genetic variants in spermatogenesis-related loci identifies new risk factors for idiopathic severe spermatogenic failure. | Guzmán-Jiménez A et al. | — | 2024 | → |
| A comprehensive whole genome database of ethnic minority populations. | He Y et al. | — | 2024 | → |
| A cost-effective sequencing method for genetic studies combining high-depth whole exome and low-depth whole genome. | Bhérer C et al. | — | 2024 | → |
| Activity-Based Acylome Profiling with <i>N</i>-(Cyanomethyl)-<i>N</i>-(phenylsulfonyl)amides for Targeted Lysine Acylation and Post-Translational Control of Protein Function in Cells. | Ryan EM et al. | — | 2024 | → |
| A deep catalogue of protein-coding variation in 983,578 individuals. | Sun KY et al. | — | 2024 | → |
| Adjusting for principal components can induce collider bias in genome-wide association studies. | Grinde KE et al. | — | 2024 | → |
| Admixture Mapping of Chronic Kidney Disease and Risk Factors in Hispanic/Latino Individuals From Central America Country of Origin. | Horimoto ARVR et al. | — | 2024 | → |
| Adult Onset Foveomacular Vitelliform Dystrophy Shows Genetic Overlap With Age-Related Macular Degeneration. | Jaskoll S et al. | — | 2024 | → |
| A genetic and proteomic comparison of key AD biomarkers across tissues. | Marsh TW et al. | — | 2024 | → |
| A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels. | de Vries PS et al. | — | 2024 | → |
| A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death. | Minnai F et al. | — | 2024 | → |
| A genome-wide association study of alloimmunization in the TOPMed OMG-SCD cohort identifies a locus on chromosome 12. | Sun Q et al. | — | 2024 | → |
| A Genome-Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid Syndrome. | Casares-Marfil D et al. | — | 2024 | → |
| A genome-wide spectrum of tandem repeat expansions in 338,963 humans. | Cui Y et al. | — | 2024 | → |
| A genomic mutational constraint map using variation in 76,156 human genomes. | Chen S et al. | — | 2024 | → |
| A Genomics England haplotype reference panel and imputation of UK Biobank. | Shi S et al. | — | 2024 | → |
| A genotype imputation reference panel specific for native Southeast Asian populations. | Cengnata A et al. | — | 2024 | → |
| AGIDB: a versatile database for genotype imputation and variant decoding across species. | Zhang K et al. | — | 2024 | → |
| Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone. | Dunn ME et al. | — | 2024 | → |
| A harmonized public resource of deeply sequenced diverse human genomes. | Koenig Z et al. | — | 2024 | → |
| Air Pollution Exposure and Interstitial Lung Features in SPIROMICS Participants with Chronic Obstructive Pulmonary Disease. | Baddour NA et al. | — | 2024 | → |
| Allele-specific transcription factor binding across human brain regions offers mechanistic insight into eQTLs. | Anderson AG et al. | — | 2024 | → |
| Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome. | Gorijala P et al. | — | 2024 | → |
| An abdominal obesity missense variant in the adipocyte thermogenesis gene TBX15 is implicated in adaptation to cold in Finns. | Deal M et al. | — | 2024 | → |
| Analysis of 1386 epileptogenic brain lesions reveals association with DYRK1A and EGFR. | Boßelmann CM et al. | — | 2024 | → |
| Analysis of gene expression in the postmortem brain of neurotypical Black Americans reveals contributions of genetic ancestry. | Benjamin KJM et al. | — | 2024 | → |
| An archaic HLA class I receptor allele diversifies natural killer cell-driven immunity in First Nations peoples of Oceania. | Loh L et al. | — | 2024 | → |
| Ancient Rapanui genomes reveal resilience and pre-European contact with the Americas. | Moreno-Mayar JV et al. | — | 2024 | → |
| An Integrative Migraine Polygenic Risk Score Is Associated with Age at Onset But Not Chronification. | Chase BA et al. | — | 2024 | → |
| A noncoding regulatory variant in IKZF1 increases acute lymphoblastic leukemia risk in Hispanic/Latino children. | de Smith AJ et al. | — | 2024 | → |
| A Novel Heterozygous NFKB2 Variant in a Multiplex Family with Common Variable Immune Deficiency and Autoantibodies Against Type I IFNs. | Baran A et al. | — | 2024 | → |
| A novel statistical framework for meta-analysis of total mediation effect with high-dimensional omics mediators in large-scale genomic consortia. | Xu Z et al. | — | 2024 | → |
| A polygenic risk score for the QT interval is an independent predictor of drug-induced QT prolongation. | Simon ST et al. | — | 2024 | → |
| Applications of genome sequencing as a single platform for clinical constitutional genetic testing. | Yang Y et al. | — | 2024 | → |
| A resampling-based approach to share reference panels. | Cavinato T et al. | — | 2024 | → |
| Aspiring toward equitable benefits from genomic advances to individuals of ancestrally diverse backgrounds. | Wang Y et al. | — | 2024 | → |
| Assessing polyomic risk to predict Alzheimer's disease using a machine learning model. | Ngai T et al. | — | 2024 | → |
| Assessing the impact of post-mortem damage and contamination on imputation performance in ancient DNA. | Garrido Marques A et al. | — | 2024 | → |
| Association analysis of mitochondrial DNA heteroplasmic variants: Methods and application. | Sun X et al. | — | 2024 | → |
| Association of asthma and bronchiectasis: Mendelian randomization analyses and observational study. | Fan R et al. | — | 2024 | → |
| Association of Blood MicroRNA Expression and Polymorphisms with Cognitive and Biomarker Changes in Older Adults. | Sadlon A et al. | — | 2024 | → |
| Association of common and rare variants with Alzheimer's disease in more than 13,000 diverse individuals with whole-genome sequencing from the Alzheimer's Disease Sequencing Project. | Lee WP et al. | — | 2024 | → |
| Association of genetic variation on X chromosome with systemic lupus erythematosus in both Thai and Chinese populations. | Tangtanatakul P et al. | — | 2024 | → |
| Association of whole-person eigen-polygenic risk scores with Alzheimer's disease. | Kharaghani A et al. | — | 2024 | → |
| Associations between fasting glucose rate-of-change and the missense variant, rs373863828, in an adult Samoan cohort. | Rivara AC et al. | — | 2024 | → |
| Associations between polygenic scores for cognitive and non-cognitive factors of educational attainment and measures of behavior, psychopathology, and neuroimaging in the adolescent brain cognitive development study. | Gorelik AJ et al. | — | 2024 | → |
| Association study of human leukocyte antigen variants and idiopathic pulmonary fibrosis. | Guillen-Guio B et al. | — | 2024 | → |
| Asymptotically exact fit for linear mixed model in genetic association studies. | Guan Y et al. | — | 2024 | → |
| Balancing the efforts of chart review and gains in PRS prediction accuracy: An empirical study. | Lei Y et al. | — | 2024 | → |
| Beyond the Human Genome Project: The Age of Complete Human Genome Sequences and Pangenome References. | Taylor DJ et al. | — | 2024 | → |
| Biobank-scale inference of multi-individual identity by descent and gene conversion. | Browning SR et al. | — | 2024 | → |
| Bioinformatics of germline variant discovery for rare disease diagnostics: current approaches and remaining challenges. | Barbitoff YA et al. | — | 2024 | → |
| Biostatistical Aspects of Whole Genome Sequencing Studies: Preprocessing and Quality Control. | Betschart RO et al. | — | 2024 | → |
| Black Americans With Sickle Cell Disease (SCD) Demonstrate Accelerated Epigenetic Pace of Aging Compared to Black Americans Without SCD. | Garrett ME et al. | — | 2024 | → |
| Blood immunophenotyping of multiple sclerosis patients at diagnosis identifies a classical monocyte subset associated to disease evolution. | Rodriguez S et al. | — | 2024 | → |
| Blood metabolites and chronic kidney disease: a Mendelian randomization study. | Hou Y et al. | — | 2024 | → |
| Brain cell-type shifts in Alzheimer's disease, autism, and schizophrenia interrogated using methylomics and genetics. | Yap CX et al. | — | 2024 | → |
| Building a vertically integrated genomic learning health system: The biobank at the Colorado Center for Personalized Medicine. | Wiley LK et al. | — | 2024 | → |
| Characterizing epigenetic aging in an adult sickle cell disease cohort. | Lê BM et al. | — | 2024 | → |
| Chromosome X-wide association study in case control studies of pathologically confirmed Alzheimer's disease in a European population. | Simmonds E et al. | — | 2024 | → |
| Circulating Blood Plasma Profiling Reveals Proteomic Signature and a Causal Role for SVEP1 in Sudden Cardiac Death. | Duong T et al. | — | 2024 | → |
| Clinical Genetic Testing for Hearing Loss: Implications for Genetic Counseling and Gene-Based Therapies. | Lee NK et al. | — | 2024 | → |
| Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials. | Marston NA et al. | — | 2024 | → |
| Colorectal Cancer Polygenic Risk Score Is Associated With Screening Colonoscopy Findings but Not Follow-Up Outcomes. | Sullivan BA et al. | — | 2024 | → |
| Common variants increase risk for congenital diaphragmatic hernia within the context of de novo variants. | Qiao L et al. | — | 2024 | → |
| Comprehensive Evaluation of the Genetic Basis of Keratoconus: New Perspectives for Clinical Translation. | Cerván-Martín M et al. | — | 2024 | → |
| Comprehensive whole-genome analyses of the UK Biobank reveal significant sex differences in both genotype missingness and allele frequency on the X chromosome. | Chen DZ et al. | — | 2024 | → |
| Corpora amylacea negatively correlate with hippocampal tau pathology in Alzheimer's disease. | Dallmeier JD et al. | — | 2024 | → |
| Correlates of Risk for Disinhibited Behaviors in the Million Veteran Program Cohort. | Barr PB et al. | — | 2024 | → |
| Critical assessment of variant prioritization methods for rare disease diagnosis within the rare genomes project. | Stenton SL et al. | — | 2024 | → |
| Cross-ancestry atlas of gene, isoform, and splicing regulation in the developing human brain. | Wen C et al. | — | 2024 | → |
| Cross-continental environmental and genome-wide association study on children and adolescent anxiety and depression. | Thapaliya B et al. | — | 2024 | → |
| Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2024. | CNCB-NGDC Members and Partners | — | 2024 | → |
| Deciphering the impact of genomic variation on function. | IGVF Consortium | — | 2024 | → |
| Decoding triancestral origins, archaic introgression, and natural selection in the Japanese population by whole-genome sequencing. | Liu X et al. | — | 2024 | → |
| Defective kinase activity of IKKα leads to combined immunodeficiency and disruption of immune tolerance in humans. | Cildir G et al. | — | 2024 | → |
| Determinants of mosaic chromosomal alteration fitness. | Pershad Y et al. | — | 2024 | → |
| Diabetes Study of Children of Diverse Ethnicity and Race: Study design. | Redondo MJ et al. | — | 2024 | → |
| Differentiated adaptative genetic architecture and language-related demographical history in South China inferred from 619 genomes from 56 populations. | Sun Q et al. | — | 2024 | → |
| Dilated Cardiomyopathy: A Genetic Journey from Past to Future. | Newman NA et al. | — | 2024 | → |
| Divergent role of Mitochondrial Amidoxime Reducing Component 1 (MARC1) in human and mouse. | Smagris E et al. | — | 2024 | → |
| Diversity of CFTR variants across ancestries characterized using 454,727 UK biobank whole exome sequences. | Ideozu JE et al. | — | 2024 | → |
| Does Thrombosis Play a Causal Role in Lacunar Stroke and Cerebral Small Vessel Disease? | Koohi F et al. | — | 2024 | → |
| Dual diagnosis of <i>UQCRFS1</i>-related mitochondrial complex III deficiency and recessive <i>GJA8</i>-related cataracts. | Blue EE et al. | — | 2024 | → |
| Editorial: Full landscape of human genomic diversity and its impact on precision medicine. | He G et al. | — | 2024 | → |
| Effect modification by sex of genetic associations of vitamin C related metabolites in the Canadian Longitudinal study on aging. | Lelievre R et al. | — | 2024 | → |
| Eicosanoids and Related Metabolites Associated with ESKD in a Community-Based Cohort. | Surapaneni AL et al. | — | 2024 | → |
| Eight quick tips for including chromosome X in genome-wide association studies. | Bellavance J et al. | — | 2024 | → |
| Epigenetic and proteomic signatures associate with clonal hematopoiesis expansion rate. | Mack TM et al. | — | 2024 | → |
| Estimation of inbreeding and kinship coefficients via latent identity-by-descent states. | Guan Y et al. | — | 2024 | → |
| Evaluating the Efficacy of Type 2 Diabetes Polygenic Risk Scores in an Independent European Population. | Brīvība M et al. | — | 2024 | → |
| Examining the role of common variants in rare neurodevelopmental conditions. | Huang QQ et al. | — | 2024 | → |
| Exploring the intersection of polygenic risk scores and prenatal alcohol exposure: Unraveling the mental health equation. | Gerlikhman L et al. | — | 2024 | → |
| Expression quantitative trait loci influence DNA damage-induced apoptosis in cancer. | Bigge J et al. | — | 2024 | → |
| Expression quantitative trait locus mapping of extracellular microRNAs in human plasma. | Huan T et al. | — | 2024 | → |
| Factors associated with genetic markers for rotator cuff disease in patients with atraumatic rotator cuff tears. | Yanik EL et al. | — | 2024 | → |
| FAVOR-GPT: a generative natural language interface to whole genome variant functional annotations. | Li TC et al. | — | 2024 | → |
| FedGMMAT: Federated generalized linear mixed model association tests. | Li W et al. | — | 2024 | → |
| Fine-mapping across diverse ancestries drives the discovery of putative causal variants underlying human complex traits and diseases. | Yuan K et al. | — | 2024 | → |
| Fine-scale genetic structure and rare variant frequencies. | Gagnon L et al. | — | 2024 | → |
| FLT3L governs the development of partially overlapping hematopoietic lineages in humans and mice. | Momenilandi M et al. | — | 2024 | → |
| From Mendel to multi-omics: shifting paradigms. | Mersha TB | — | 2024 | → |
| Functional genomics in inborn errors of immunity. | Hurabielle C et al. | — | 2024 | → |
| Functional variants in a TTTG microsatellite on 15q26.1 cause familial nonautoimmune thyroid abnormalities. | Narumi S et al. | — | 2024 | → |
| Gene-based association study of rare variants in children of diverse ancestries implicates TNFRSF21 in the development of allergic asthma. | Clay S et al. | — | 2024 | → |
| Gene expression and splicing QTL analysis of blood cells in African American participants from the Jackson Heart Study. | Wen J et al. | — | 2024 | → |
| Generation Scotland: an update on Scotland's longitudinal family health study. | Milbourn H et al. | — | 2024 | → |
| Gene regulatory network inference from CRISPR perturbations in primary CD4<sup>+</sup> T cells elucidates the genomic basis of immune disease. | Weinstock JS et al. | — | 2024 | → |
| Genetic Analysis of Perceived Youthfulness Reveals Differences in How Men's and Women's Age Is Assessed. | Ingold N et al. | — | 2024 | → |
| Genetic and Environmental Factors in Autoimmune Thyroid Disease: Exploring Associations with Selenium Levels and Novel Loci in a Latvian Cohort. | Upmale-Engela S et al. | — | 2024 | → |
| Genetic architecture of cerebrospinal fluid and brain metabolite levels and the genetic colocalization of metabolites with human traits. | Wang C et al. | — | 2024 | → |
| Genetic Architecture of Neurological Disorders and Their Endophenotypes: Insights from Genetic Association Studies. | Sargurupremraj M | — | 2024 | → |
| Genetic architecture of routinely acquired blood tests in a British South Asian cohort. | Jacobs BM et al. | — | 2024 | → |
| Genetic determinants and phenotypic consequences of blood T-cell proportions in 207,000 diverse individuals. | Poisner H et al. | — | 2024 | → |
| Genetic determinants of serum bilirubin using inferred native American gene variants in Chilean adolescents. | Miranda JP et al. | — | 2024 | → |
| Genetic drivers of heterogeneity in type 2 diabetes pathophysiology. | Suzuki K et al. | — | 2024 | → |
| Genetic modifiers of body mass index in individuals with cystic fibrosis. | Ling H et al. | — | 2024 | → |
| Genetic risk factors for Mesoamerican nephropathy. | Friedman DJ et al. | — | 2024 | → |
| Genetics of cell-type-specific post-transcriptional gene regulation during human neurogenesis. | Aygün N et al. | — | 2024 | → |
| Genetics of glucose homeostasis in pregnancy and postpartum. | Lowe WL et al. | — | 2024 | → |
| Genetics of Latin American Diversity Project: Insights into population genetics and association studies in admixed groups in the Americas. | Borda V et al. | — | 2024 | → |
| Genetics of Parkinson's disease heterogeneity: A genome-wide association study of clinical subtypes. | Dulski J et al. | — | 2024 | → |
| Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes. | Farrell K et al. | — | 2024 | → |
| Genetic variation across and within individuals. | Yu Z et al. | — | 2024 | → |
| Genetic versus self-reported African ancestry of the recipient and neighborhood predictors of kidney transplantation outcomes in 2 multiethnic urban cohorts. | Zanoni F et al. | — | 2024 | → |
| Genome-wide analyses of neonatal jaundice reveal a marked departure from adult bilirubin metabolism. | Solé-Navais P et al. | — | 2024 | → |
| Genome-wide association studies identify novel loci in rapidly progressive Alzheimer's disease. | Wang P et al. | — | 2024 | → |
| Genome-Wide Association Studies of 3 Distinct Recovery Phenotypes in Mild Ischemic Stroke. | Aldridge CM et al. | — | 2024 | → |
| Genome-Wide Interaction Analyses of Serum Calcium on Ventricular Repolarization Time in 125 393 Participants. | Young WJ et al. | — | 2024 | → |
| Genome-Wide Mendelian Randomization Study Reveals Druggable Genes for Cerebral Small Vessel Disease. | Yang XZ et al. | — | 2024 | → |
| Genome-Wide Meta-analysis Identifies Risk Loci and Improves Disease Prediction of Age-Related Macular Degeneration. | He W et al. | — | 2024 | → |
| Genome-wide study investigating effector genes and polygenic prediction for kidney function in persons with ancestry from Africa and the Americas. | Hughes O et al. | — | 2024 | → |
| Genomic Analysis Identifies Risk Factors in Restless Legs Syndrome. | Akçimen F et al. | — | 2024 | → |
| Genomic data in the All of Us Research Program. | All of Us Research Program Genomics Investigators | — | 2024 | → |
| Genotype imputation methods for whole and complex genomic regions utilizing deep learning technology. | Naito T et al. | — | 2024 | → |
| Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity. | Houlahan KE et al. | — | 2024 | → |
| Germline Polymorphisms Associated with Overall Survival in Lung Adenocarcinoma: Genome-Wide Analysis. | Minnai F et al. | — | 2024 | → |
| Germline variation contributes to false negatives in CRISPR-based experiments with varying burden across ancestries. | Misek SA et al. | — | 2024 | → |
| GWAS of multiple neuropathology endophenotypes identifies new risk loci and provides insights into the genetic risk of dementia. | Shade LMP et al. | — | 2024 | → |
| Helper T cell immunity in humans with inherited CD4 deficiency. | Guérin A et al. | — | 2024 | → |
| Hemochromatosis neural archetype reveals iron disruption in motor circuits. | Loughnan R et al. | — | 2024 | → |
| Homorepeat variability within the human population. | Mier P et al. | — | 2024 | → |
| Human ITGAV variants are associated with immune dysregulation, brain abnormalities, and colitis. | Ghasempour S et al. | — | 2024 | → |
| Identification and functional characterisation of DNA methylation differences between East- and West-originating Finns. | Ciantar J et al. | — | 2024 | → |
| Identification of a mosaic MTOR variant in purified neuronal DNA in a patient with focal cortical dysplasia using a novel depth electrode harvesting technique. | Klein KM et al. | — | 2024 | → |
| Identification of Clonal Hematopoiesis Driver Mutations through In Silico Saturation Mutagenesis. | Demajo S et al. | — | 2024 | → |
| Identification of novel loci for multiple myeloma when comparing with its precursor condition monoclonal gammopathy of unknown significance. | Buradagunta CS et al. | — | 2024 | → |
| Illuminating the function of the orphan transporter, SLC22A10, in humans and other primates. | Yee SW et al. | — | 2024 | → |
| Impact of the inaccessible genome on genotype imputation and genome-wide association studies. | König E et al. | — | 2024 | → |
| Improved sequence mapping using a complete reference genome and lift-over. | Chen NC et al. | — | 2024 | → |
| Improving polygenic risk prediction in admixed populations by explicitly modeling ancestral-differential effects via GAUDI. | Sun Q et al. | — | 2024 | → |
| Improving population scale statistical phasing with whole-genome sequencing data. | Wertenbroek R et al. | — | 2024 | → |
| Imputation accuracy across global human populations. | Cahoon JL et al. | — | 2024 | → |
| Imputation Server PGS: an automated approach to calculate polygenic risk scores on imputation servers. | Forer L et al. | — | 2024 | → |
| Increased frequency of repeat expansion mutations across different populations. | Ibañez K et al. | — | 2024 | → |
| Increasing the diagnostic yield of childhood glaucoma cases recruited into the 100,000 Genomes Project. | Al-Saei O et al. | — | 2024 | → |
| Individual and Neighborhood-level Socioeconomic Status and Somatic Mutations Associated With Increased Risk of Cardiovascular Disease and Mortality: A Cross-Sectional Analysis in the Women's Health Initiative. | Love SM et al. | — | 2024 | → |
| Inferring a directed acyclic graph of phenotypes from GWAS summary statistics. | Zilinskas R et al. | — | 2024 | → |
| Integrated nasopharyngeal airway metagenome and asthma genetic risk endotyping of severe bronchiolitis in infancy and risk of childhood asthma. | Zhu Z et al. | — | 2024 | → |
| Interaction molecular QTL mapping discovers cellular and environmental modifiers of genetic regulatory effects. | Kasela S et al. | — | 2024 | → |
| Investigating the role of common cis-regulatory variants in modifying penetrance of putatively damaging, inherited variants in severe neurodevelopmental disorders. | Wigdor EM et al. | — | 2024 | → |
| Investigation of genetic determinants of cognitive change in later life. | Mahedy L et al. | — | 2024 | → |
| Legal aspects of privacy-enhancing technologies in genome-wide association studies and their impact on performance and feasibility. | Brauneck A et al. | — | 2024 | → |
| Leveraging sex-genetic interactions to understand brain disorders: recent advances and current gaps. | Neale N et al. | — | 2024 | → |
| Longitudinal change in memory performance as a strong endophenotype for Alzheimer's disease. | Archer DB et al. | — | 2024 | → |
| <i>ENAM</i> Mutations Can Cause Hypomaturation Amelogenesis Imperfecta. | Wang YL et al. | — | 2024 | → |
| <i>NUDCD3</i> deficiency disrupts V(D)J recombination to cause SCID and Omenn syndrome. | Chen R et al. | — | 2024 | → |
| Machine learning models for predicting blood pressure phenotypes by combining multiple polygenic risk scores. | Hrytsenko Y et al. | — | 2024 | → |
| Machine Learning Models of Polygenic Risk for Enhanced Prediction of Alzheimer Disease Endophenotypes. | Gunter NB et al. | — | 2024 | → |
| Metabolomic and genetic architecture of gestational diabetes subtypes. | Lee K et al. | — | 2024 | → |
| Metagenomic Study of the MESA: Detection of <i>Gemella Morbillorum</i> and Association With Coronary Heart Disease. | Taylor KD et al. | — | 2024 | → |
| Mexican Health and Aging Study Biomarker and Genetic Data Profile. | Samper-Ternent R et al. | — | 2024 | → |
| MGA loss-of-function variants cause premature ovarian insufficiency. | Tang S et al. | — | 2024 | → |
| Mistranslating the genetic code with leucine in yeast and mammalian cells. | Davey-Young J et al. | — | 2024 | → |
| Modeling recent positive selection using identity-by-descent segments. | Temple SD et al. | — | 2024 | → |
| Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions. | Purdue MP et al. | — | 2024 | → |
| Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease Based on an Ancestrally Diverse Genome-Wide Association Study and Population-Specific Optimization. | Smith JL et al. | — | 2024 | → |
| Mutational landscape of risk variants in comorbid depression and obesity: a next-generation sequencing approach. | Pérez-Gutiérrez AM et al. | — | 2024 | → |
| Native Hawaiian and Pacific Islander populations in genomic research. | Ha EK et al. | — | 2024 | → |
| Parallelized engineering of mutational models using piggyBac transposon delivery of CRISPR libraries. | Nuttle X et al. | — | 2024 | → |
| Pathogenic variants in autism gene <i>KATNAL2</i> cause hydrocephalus and disrupt neuronal connectivity by impairing ciliary microtubule dynamics. | DeSpenza T et al. | — | 2024 | → |
| Person-specific differences in ubiquitin-proteasome mediated proteostasis in human neurons. | Hsieh YC et al. | — | 2024 | → |
| Pharmacogenomic landscape of the Thai population from genome sequencing of 949 individuals. | Piriyapongsa J et al. | — | 2024 | → |
| Phenotype wide association study links bronchopulmonary dysplasia with eosinophilia in children. | Kelchtermans J et al. | — | 2024 | → |
| Plasma pQTL and brain eQTL integration identifies PNKP as a therapeutic target and reveals mechanistic insights into migraine pathophysiology. | Lou J et al. | — | 2024 | → |
| Polygenic Indices (a.k.a. Polygenic Scores) in Social Science: A Guide for Interpretation and Evaluation. | Burt CH | — | 2024 | → |
| Polygenic Prediction of Keratoconus and its Measures: Cross-Sectional and Longitudinal Analyses in Community-Based Young Adults. | Lee SS et al. | — | 2024 | → |
| Polygenic risk scores for cardiometabolic traits demonstrate importance of ancestry for predictive precision medicine. | Kember RL et al. | — | 2024 | → |
| Polygenic Scores and Preclinical Cardiovascular Disease in Individuals With HIV: Insights From the REPRIEVE Trial. | Zou RS et al. | — | 2024 | → |
| Polygenic Scores Clarify the Relationship Between Mental Health and Gender Diversity. | Thomas TR et al. | — | 2024 | → |
| Polygenic scores for tobacco use provide insights into systemic health risks in a diverse EHR-linked biobank in Los Angeles. | Venkateswaran V et al. | — | 2024 | → |
| Population-specific reference panel improves imputation quality for genome-wide association studies conducted on the Japanese population. | Flanagan J et al. | — | 2024 | → |
| Precision psychiatry and Research Domain Criteria: Implications for clinical trials and future practice. | Williams LM et al. | — | 2024 | → |
| Predicting Functional Consequences of Recent Natural Selection in Britain. | Poyraz L et al. | — | 2024 | → |
| Principles and methods for transferring polygenic risk scores across global populations. | Kachuri L et al. | — | 2024 | → |
| Prioritizing disease-related rare variants by integrating gene expression data. | Guo H et al. | — | 2024 | → |
| Proteome-wide Mendelian randomization identifies causal plasma proteins in lung cancer. | Li H et al. | — | 2024 | → |
| Proteomic networks and related genetic variants associated with smoking and chronic obstructive pulmonary disease. | Konigsberg IR et al. | — | 2024 | → |
| ProtVar: mapping and contextualizing human missense variation. | Stephenson JD et al. | — | 2024 | → |
| Rare coding variant analysis for human diseases across biobanks and ancestries. | Jurgens SJ et al. | — | 2024 | → |
| Rare disease genomics and precision medicine. | Hong J et al. | — | 2024 | → |
| Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer's disease. | Bhattarai P et al. | — | 2024 | → |
| Rare variant analyses in 51,256 type 2 diabetes cases and 370,487 controls reveal the pathogenicity spectrum of monogenic diabetes genes. | Huerta-Chagoya A et al. | — | 2024 | → |
| Rare variant contribution to the heritability of coronary artery disease. | Rocheleau G et al. | — | 2024 | → |
| RAVAR: a curated repository for rare variant-trait associations. | Cao C et al. | — | 2024 | → |
| Recombinant IFN-γ1b Treatment in a Patient with Inherited IFN-γ Deficiency. | Rosain J et al. | — | 2024 | → |
| Refined preferences of prioritizers improve intelligent diagnosis for Mendelian diseases. | Yuan X et al. | — | 2024 | → |
| Saturation genome editing maps the functional spectrum of pathogenic VHL alleles. | Buckley M et al. | — | 2024 | → |
| scAbsolute: measuring single-cell ploidy and replication status. | Schneider MP et al. | — | 2024 | → |
| Schizophrenia genomics: genetic complexity and functional insights. | Sullivan PF et al. | — | 2024 | → |
| Search for chromosomal instability aiding variants reveal naturally occurring kinetochore gene variants that perturb chromosome segregation. | Islam A et al. | — | 2024 | → |
| Semi-supervised machine learning method for predicting homogeneous ancestry groups to assess Hardy-Weinberg equilibrium in diverse whole-genome sequencing studies. | Shyr D et al. | — | 2024 | → |
| Sex affects transcriptional associations with schizophrenia across the dorsolateral prefrontal cortex, hippocampus, and caudate nucleus. | Benjamin KJM et al. | — | 2024 | → |
| Sex-specific genetic architecture of late-life memory performance. | Eissman JM et al. | — | 2024 | → |
| shaPRS: Leveraging shared genetic effects across traits or ancestries improves accuracy of polygenic scores. | Kelemen M et al. | — | 2024 | → |
| Single-cell multi-cohort dissection of the schizophrenia transcriptome. | Ruzicka WB et al. | — | 2024 | → |
| Single-Cell Transcriptomic and Targeted Genomic Profiling Adjusted for Inflammation and Therapy Bias Reveal <i>CRTAM</i> and <i>PLCB1</i> as Novel Hub Genes for Anti-Tumor Necrosis Factor Alpha Therapy Response in Crohn's Disease. | Gorenjak M et al. | — | 2024 | → |
| Single-nucleotide variant calling in single-cell sequencing data with Monopogen. | Dou J et al. | — | 2024 | → |
| Small polymorphisms are a source of ancestral bias in structural variant breakpoint placement. | Audano PA et al. | — | 2024 | → |
| Somatic mosaicism in schizophrenia brains reveals prenatal mutational processes. | Maury EA et al. | — | 2024 | → |
| South Asia: The Missing Diverse in Diversity. | Dokuru DR et al. | — | 2024 | → |
| Special Issue "Personalized Medicine in Blood Disease of Children". | Ceci A et al. | — | 2024 | → |
| Stimulating Wnt signaling reveals context-dependent genetic effects on gene regulation in primary human neural progenitors. | Matoba N et al. | — | 2024 | → |
| St. Jude Survivorship Portal: Sharing and Analyzing Large Clinical and Genomic Datasets from Pediatric Cancer Survivors. | Matt GY et al. | — | 2024 | → |
| SynGAP regulates synaptic plasticity and cognition independently of its catalytic activity. | Araki Y et al. | — | 2024 | → |
| Systematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson's disease. | Hop PJ et al. | — | 2024 | → |
| Systematic Review and Phenome-Wide Scans of Genetic Associations with Vascular Cognitive Impairment. | Diany R et al. | — | 2024 | → |
| TAD boundary deletion causes PITX2-related cardiac electrical and structural defects. | Baudic M et al. | — | 2024 | → |
| Thalamocortical organoids enable in vitro modeling of 22q11.2 microdeletion associated with neuropsychiatric disorders. | Shin D et al. | — | 2024 | → |
| The Born in Guangzhou Cohort Study enables generational genetic discoveries. | Huang S et al. | — | 2024 | → |
| The Egypt Genome Project. | Elmonem MA et al. | — | 2024 | → |
| The first genome-wide association study in the Argentinian and Chilean populations identifies shared genetics with Europeans in Alzheimer's disease. | Dalmasso MC et al. | — | 2024 | → |
| The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria. | Ojewunmi OO et al. | — | 2024 | → |
| The hazards of genotype imputation when mapping disease susceptibility variants. | Lau W et al. | — | 2024 | → |
| The predictive capacity of polygenic risk scores for disease risk is only moderately influenced by imputation panels tailored to the target population. | Levi H et al. | — | 2024 | → |
| The PREVENT dementia programme: baseline demographic, lifestyle, imaging and cognitive data from a midlife cohort study investigating risk factors for dementia. | Ritchie CW et al. | — | 2024 | → |
| The PRIMED Consortium: Reducing disparities in polygenic risk assessment. | Kullo IJ et al. | — | 2024 | → |
| TOPMed imputed genomics enhances genomic atlas of the human proteome in brain, cerebrospinal fluid, and plasma. | Yi H et al. | — | 2024 | → |
| Transcriptome-wide association study of the plasma proteome reveals cis and trans regulatory mechanisms underlying complex traits. | Wittich H et al. | — | 2024 | → |
| Two-stage strategy using denoising autoencoders for robust reference-free genotype imputation with missing input genotypes. | Kojima K et al. | — | 2024 | → |
| Type 1 diabetes genetic risk score variation across ancestries using whole genome sequencing and array-based approaches. | Arni AM et al. | — | 2024 | → |
| Uncovering novel regulatory variants in carbohydrate metabolism: a comprehensive multi-omics study of glycemic traits in the Indian population. | Nair JM et al. | — | 2024 | → |
| Using computational approaches to enhance the interpretation of missense variants in the PAX6 gene. | Andhika NS et al. | — | 2024 | → |
| Validation of biomarkers of aging. | Moqri M et al. | — | 2024 | → |
| Variants in autophagy genes MTMR12 and FAM134A are putative modifiers of the hepatic phenotype in α1-antitrypsin deficiency. | Tafaleng EN et al. | — | 2024 | → |
| Variant-to-function analysis of the childhood obesity chr12q13 locus implicates rs7132908 as a causal variant within the 3' UTR of FAIM2. | Littleton SH et al. | — | 2024 | → |
| Whole-Exome Analysis for Polish Caucasian Patients with Retinal Dystrophies and the Creation of a Reference Genomic Database for the Polish Population. | Matczyńska E et al. | — | 2024 | → |
| Whole-exome sequencing for genetic diagnosis of idiopathic liver injury in children. | Lülecioğlu AA et al. | — | 2024 | → |
| Whole-genome analysis of plasma fibrinogen reveals population-differentiated genetic regulators with putative liver roles. | Huffman JE et al. | — | 2024 | → |
| Whole genome sequencing based analysis of inflammation biomarkers in the Trans-Omics for Precision Medicine (TOPMed) consortium. | Jiang MZ et al. | — | 2024 | → |
| Whole-genome sequencing in 333,100 individuals reveals rare non-coding single variant and aggregate associations with height. | Hawkes G et al. | — | 2024 | → |
| Whole genome sequencing in clinical practice. | Bagger FO et al. | — | 2024 | → |
| Whole genome sequencing of 4,787 individuals identifies gene-based rare variants in age-related macular degeneration. | Kwong A et al. | — | 2024 | → |
| Whole-genome sequencing reveals rare variants associated with gout in Taiwanese males. | Tseng YP et al. | — | 2024 | → |
| Whole-genome sequencing study in Koreans identifies novel loci for Alzheimer's disease. | Kang M et al. | — | 2024 | → |
| X-linked genetic associations in sporadic thoracic aortic dissection. | Musfee FI et al. | — | 2024 | → |
| Yield of genetic association signals from genomes, exomes and imputation in the UK Biobank. | Gaynor SM et al. | — | 2024 | → |
| Aagenaes syndrome/lymphedema cholestasis syndrome 1 is caused by a founder variant in the 5'-untranslated region of UNC45A. | Almaas R et al. | — | 2023 | → |
| Accurate phenotypic classification and exome sequencing allow identification of novel genes and variants associated with adult-onset hearing loss. | Lewis MA et al. | — | 2023 | → |
| Accurate rare variant phasing of whole-genome and whole-exome sequencing data in the UK Biobank. | Hofmeister RJ et al. | — | 2023 | → |
| A diverse ancestrally-matched reference panel increases genotype imputation accuracy in a underrepresented population. | Mauleekoonphairoj J et al. | — | 2023 | → |
| A framework for individualized splice-switching oligonucleotide therapy. | Kim J et al. | — | 2023 | → |
| Age at Menopause, Leukocyte Telomere Length, and Coronary Artery Disease in Postmenopausal Women. | Schuermans A et al. | — | 2023 | → |
| A genome-wide association, polygenic risk score and sex study on opioid use disorder treatment outcomes. | McEvoy A et al. | — | 2023 | → |
| A genome-wide association study identifies 41 loci associated with eicosanoid levels. | Rhee EP et al. | — | 2023 | → |
| A Genome-Wide Association Study of Small Cell Lung Cancer. | Enjo-Barreiro JR et al. | — | 2023 | → |
| A genome-wide search for pleiotropy in more than 100,000 harmonized longitudinal cognitive domain scores. | Kang M et al. | — | 2023 | → |
| A genomic data archive from the Network for Pancreatic Organ donors with Diabetes. | Perry DJ et al. | — | 2023 | → |
| A GWAS in the pandemic epicenter highlights the severe COVID-19 risk locus introgressed by Neanderthals. | Breno M et al. | — | 2023 | → |
| A high-resolution haplotype-resolved Reference panel constructed from the China Kadoorie Biobank Study. | Yu C et al. | — | 2023 | → |
| A large meta-analysis identifies genes associated with anterior uveitis. | Gelfman S et al. | — | 2023 | → |
| A Large-Scale Exome-Wide Association Study Identifies Novel Germline Mutations in Lung Cancer. | Shen S et al. | — | 2023 | → |
| An epidemiological introduction to human metabolomic investigations. | Joshi AD et al. | — | 2023 | → |
| A novel splice-site FHOD3 founder variant is a common cause of hypertrophic cardiomyopathy in the population of the Balkans-A cohort study. | Vodnjov N et al. | — | 2023 | → |
| A pan-tissue survey of mosaic chromosomal alterations in 948 individuals. | Gao T et al. | — | 2023 | → |
| APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry. | Belloy ME et al. | — | 2023 | → |
| Assessing and mitigating privacy risks of sparse, noisy genotypes by local alignment to haplotype databases. | Emani PS et al. | — | 2023 | → |
| Assessing a Polygenic Risk Score for Lung Cancer Susceptibility in Non-Hispanic White and Black Populations. | Trendowski MR et al. | — | 2023 | → |
| Association between Neuroligin-1 polymorphism and plasma glutamine levels in individuals with autism spectrum disorder. | Lee IH et al. | — | 2023 | → |
| Association Between Whole Blood-Derived Mitochondrial DNA Copy Number, Low-Density Lipoprotein Cholesterol, and Cardiovascular Disease Risk. | Liu X et al. | — | 2023 | → |
| Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial. | Kany S et al. | — | 2023 | → |
| A whole-genome reference panel of 14,393 individuals for East Asian populations accelerates discovery of rare functional variants. | Choi J et al. | — | 2023 | → |
| Bridging the diversity gap: Analytical and study design considerations for improving the accuracy of trans-ancestry genetic prediction. | Bocher O et al. | — | 2023 | → |
| Building a collaborative cloud platform to accelerate heart, lung, blood, and sleep research. | Ahalt S et al. | — | 2023 | → |
| Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. | Wang A et al. | — | 2023 | → |
| ChArmTelo Enables Large-Scale Chromosome Arm-Level Telomere Analysis across Human Populations and in Cancer Patients. | Guo M et al. | — | 2023 | → |
| Clinical and Genetic Atrial Fibrillation Risk and Discrimination of Cardioembolic From Noncardioembolic Stroke. | Weng LC et al. | — | 2023 | → |
| Clinical Impact of Single Nucleotide Polymorphism in CD-19 on Treatment Outcome in FMC63-CAR-T Cell Therapy. | Seipel K et al. | — | 2023 | → |
| Clinical utility of polygenic scores for cardiometabolic disease in Arabs. | Shim I et al. | — | 2023 | → |
| Clonal hematopoiesis is associated with protection from Alzheimer's disease. | Bouzid H et al. | — | 2023 | → |
| Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk. | Tobias DK et al. | — | 2023 | → |
| Common genetic variants contribute to heritability of age at onset of schizophrenia. | Sada-Fuente E et al. | — | 2023 | → |
| Comparison of multiple imputation and other methods for the analysis of imputed genotypes. | Auer PL et al. | — | 2023 | → |
| COVID-19 severity: does the genetic landscape of rare variants matter? | Khadzhieva MB et al. | — | 2023 | → |
| Deep integrative models for large-scale human genomics. | Sigurdsson AI et al. | — | 2023 | → |
| Distinct transcriptomic profiles in children prior to the appearance of type 1 diabetes-linked islet autoantibodies and following enterovirus infection. | Lin J et al. | — | 2023 | → |
| Evaluating the use of blood pressure polygenic risk scores across race/ethnic background groups. | Kurniansyah N et al. | — | 2023 | → |
| Evolutionary Action-Machine Learning Model Identifies Candidate Genes Associated With Early-Onset Coronary Artery Disease. | Shapiro D et al. | — | 2023 | → |
| eXclusionarY: 10 years later, where are the sex chromosomes in GWASs? | Sun L et al. | — | 2023 | → |
| Extensive genetic admixture between Tai-Kadai-speaking people and their neighbours in the northeastern region of the Yungui Plateau inferred from genome-wide variations. | Wang J et al. | — | 2023 | → |
| Federated generalized linear mixed models for collaborative genome-wide association studies. | Li W et al. | — | 2023 | → |
| Gene expression in African Americans, Puerto Ricans and Mexican Americans reveals ancestry-specific patterns of genetic architecture. | Kachuri L et al. | — | 2023 | → |
| Gene Regulatory Networks in Coronary Artery Disease. | Cheng J et al. | — | 2023 | → |
| Genetic regulators of sputum mucin concentration and their associations with COPD phenotypes. | Van Buren E et al. | — | 2023 | → |
| Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis. | Ramanan VK et al. | — | 2023 | → |
| Genetic risk variants for childhood nephrotic syndrome and corticosteroid response. | Cason RK et al. | — | 2023 | → |
| Genetics of cannabis use in opioid use disorder: A genome-wide association and polygenic risk score study. | Hillmer A et al. | — | 2023 | → |
| Genome mining yields putative disease-associated ROMK variants with distinct defects. | Nguyen NH et al. | — | 2023 | → |
| Genome-wide analysis of a model-derived binge eating disorder phenotype identifies risk loci and implicates iron metabolism. | Burstein D et al. | — | 2023 | → |
| Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH. | Li JH et al. | — | 2023 | → |
| Genome-wide association studies and fine-mapping identify genomic loci for n-3 and n-6 polyunsaturated fatty acids in Hispanic American and African American cohorts. | Yang C et al. | — | 2023 | → |
| Genome-wide association study identifies novel candidate malaria resistance genes in Cameroon. | Esoh KK et al. | — | 2023 | → |
| Genomic Innovation in Early Life Cardiovascular Disease Prevention and Treatment. | Li C et al. | — | 2023 | → |
| Genotype imputation accuracy and the quality metrics of the minor ancestry in multi-ancestry reference panels. | Shi M et al. | — | 2023 | → |
| Genotyping and population characteristics of the China Kadoorie Biobank. | Walters RG et al. | — | 2023 | → |
| Genotyping, sequencing and analysis of 140,000 adults from Mexico City. | Ziyatdinov A et al. | — | 2023 | → |
| GWAS for the composite traits of hematuria and albuminuria. | Gagliano Taliun SA et al. | — | 2023 | → |
| High-throughput PRIME-editing screens identify functional DNA variants in the human genome. | Ren X et al. | — | 2023 | → |
| Imputation of ancient human genomes. | Sousa da Mota B et al. | — | 2023 | → |
| Imputation of low-coverage sequencing data from 150,119 UK Biobank genomes. | Rubinacci S et al. | — | 2023 | → |
| Increasing serum iron levels and their role in the risk of infectious diseases: a Mendelian randomization approach. | Butler-Laporte G et al. | — | 2023 | → |
| Inference on the Genetic Architecture of Breast Cancer Risk. | Yasui Y et al. | — | 2023 | → |
| Integrating genetics with single-cell multiomic measurements across disease states identifies mechanisms of beta cell dysfunction in type 2 diabetes. | Wang G et al. | — | 2023 | → |
| Isoform-level transcriptome-wide association uncovers genetic risk mechanisms for neuropsychiatric disorders in the human brain. | Bhattacharya A et al. | — | 2023 | → |
| LATE-NC risk alleles (in TMEM106B, GRN, and ABCC9 genes) among persons with African ancestry. | Katsumata Y et al. | — | 2023 | → |
| Matching variants for functional characterization of genetic variants. | Cevik S et al. | — | 2023 | → |
| Meta-Analyses of Genome-Wide Association Studies for Postpartum Depression. | Guintivano J et al. | — | 2023 | → |
| Mosaic chromosomal alterations in blood across ancestries using whole-genome sequencing. | Jakubek YA et al. | — | 2023 | → |
| Multi-ancestry epigenome-wide analyses identify methylated sites associated with aortic augmentation index in TOPMed MESA. | Hu X et al. | — | 2023 | → |
| Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals. | Zhou H et al. | — | 2023 | → |
| Multi-ethnic Imputation System (MI-System): A genotype imputation server for high-dimensional data. | Chattopadhyay A et al. | — | 2023 | → |
| Multi-omics identifies large mitoribosomal subunit instability caused by pathogenic MRPL39 variants as a cause of pediatric onset mitochondrial disease. | Amarasekera SSC et al. | — | 2023 | → |
| Multiset correlation and factor analysis enables exploration of multi-omics data. | Brown BC et al. | — | 2023 | → |
| Multivariate adaptive shrinkage improves cross-population transcriptome prediction and association studies in underrepresented populations. | Araujo DS et al. | — | 2023 | → |
| Mutation of key signaling regulators of cerebrovascular development in vein of Galen malformations. | Zhao S et al. | — | 2023 | → |
| New Approaches for Targeting PCSK9: Small-Interfering Ribonucleic Acid and Genome Editing. | Oostveen RF et al. | — | 2023 | → |
| Novel loci for Alzheimer's disease identified by a genome-wide association study in Ashkenazi Jews. | Li D et al. | — | 2023 | → |
| Nutrigenomics and redox regulation: Concepts relating to the Special Issue on nutrigenomics. | Klotz LO et al. | — | 2023 | → |
| Parent-reported child appetite moderates relationships between child genetic obesity risk and parental feeding practices. | Jansen E et al. | — | 2023 | → |
| Polygenic risk score for Parkinson's disease and olfaction among middle-aged to older women. | Cao Z et al. | — | 2023 | → |
| Polygenic scores in cancer. | Yang X et al. | — | 2023 | → |
| Pragmatic Approach to Applying Polygenic Risk Scores to Diverse Populations. | Patel AP et al. | — | 2023 | → |
| Predicted leukocyte telomere length and risk of myeloid neoplasms. | Sullivan SM et al. | — | 2023 | → |
| Prevalence and significance of clonal hematopoiesis of indeterminate potential in lung transplant recipients. | Swaminathan AC et al. | — | 2023 | → |
| PSMC3 proteasome subunit variants are associated with neurodevelopmental delay and type I interferon production. | Ebstein F et al. | — | 2023 | → |
| Psychiatric polygenic risk as a predictor of COVID-19 risk and severity: insight into the genetic overlap between schizophrenia and COVID-19. | Alemany-Navarro M et al. | — | 2023 | → |
| RaPID-Query for fast identity by descent search and genealogical analysis. | Wei Y et al. | — | 2023 | → |
| Rare coding variants in CHRNB2 reduce the likelihood of smoking. | Rajagopal VM et al. | — | 2023 | → |
| Rare de novo gain-of-function missense variants in DOT1L are associated with developmental delay and congenital anomalies. | Nil Z et al. | — | 2023 | → |
| Rare penetrant mutations confer severe risk of common diseases. | Fiziev PP et al. | — | 2023 | → |
| Rare variants in long non-coding RNAs are associated with blood lipid levels in the TOPMed whole-genome sequencing study. | Wang Y et al. | — | 2023 | → |
| Rare Variants in Primary Immunodeficiency Genes and Their Functional Partners in Severe COVID-19. | Khadzhieva MB et al. | — | 2023 | → |
| Recent positive selection signatures reveal phenotypic evolution in the Han Chinese population. | Luo H et al. | — | 2023 | → |
| Reconstruction of private genomes through reference-based genotype imputation. | Mosca MJ et al. | — | 2023 | → |
| Recurrent mutation in the ancestry of a rare variant. | Wakeley J et al. | — | 2023 | → |
| Refining the genetic risk of breast cancer with rare haplotypes and pattern mining. | Letsou W et al. | — | 2023 | → |
| SAMHD1 single nucleotide polymorphisms impact outcome in children with newly diagnosed acute myeloid leukemia. | Marrero RJ et al. | — | 2023 | → |
| Shared genetic risk loci between Alzheimer's disease and related dementias, Parkinson's disease, and amyotrophic lateral sclerosis. | Wainberg M et al. | — | 2023 | → |
| Single Nucleotide Polymorphisms Associated With Motor Recovery in Patients With Nondisabling Stroke: GWAS Study. | Aldridge CM et al. | — | 2023 | → |
| SLCO5A1 and synaptic assembly genes contribute to impulsivity in juvenile myoclonic epilepsy. | Roshandel D et al. | — | 2023 | → |
| Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease. | Gupta Y et al. | — | 2023 | → |
| Tensor Decomposition-based Feature Extraction and Classification to Detect Natural Selection from Genomic Data. | Amin MR et al. | — | 2023 | → |
| The effects of pathogenic and likely pathogenic variants for inherited hemostasis disorders in 140 214 UK Biobank participants. | Stefanucci L et al. | — | 2023 | → |
| The <i>HLA-B*57:01</i> allele corresponds to a very large <i>MHC</i> haploblock likely explaining its massive effect for HIV-1 elite control. | Rahmouni M et al. | — | 2023 | → |
| The landscape of tolerated genetic variation in humans and primates. | Gao H et al. | — | 2023 | → |
| The technological landscape and applications of single-cell multi-omics. | Baysoy A et al. | — | 2023 | → |
| Toward Identification of Functional Sequences and Variants in Noncoding DNA. | Monti R et al. | — | 2023 | → |
| Trans-ancestry meta-analysis of genome wide association studies of inhibitory control. | Arnatkeviciute A et al. | — | 2023 | → |
| Two-Sample Mendelian Randomization detects bidirectional causality between gut microbiota and celiac disease in individuals with high genetic risk. | González-García BP et al. | — | 2023 | → |
| Unappreciated subcontinental admixture in Europeans and European Americans and implications for genetic epidemiology studies. | Gouveia MH et al. | — | 2023 | → |
| Unravelling the genetic architecture of human complex traits through whole genome sequencing. | Bocher O et al. | — | 2023 | → |
| Updated recommendations for CFTR carrier screening: A position statement of the American College of Medical Genetics and Genomics (ACMG). | Deignan JL et al. | — | 2023 | → |
| Whole genome sequence analysis of apparent treatment resistant hypertension status in participants from the Trans-Omics for Precision Medicine program. | Armstrong ND et al. | — | 2023 | → |
| Whole-genome sequencing across 449 samples spanning 47 ethnolinguistic groups provides insights into genetic diversity in Nigeria. | Joshi E et al. | — | 2023 | → |
| Whole-Genome Sequencing Analysis of Human Metabolome in Multi-Ethnic Populations. | Feofanova EV et al. | — | 2023 | → |
| Whole-Genome Sequencing of 502 Individuals from Latvia: The First Step towards a Population-Specific Reference of Genetic Variation. | Reščenko R et al. | — | 2023 | → |
| Whole-genome sequencing uncovers two loci for coronary artery calcification and identifies ARSE as a regulator of vascular calcification. | de Vries PS et al. | — | 2023 | → |
| X-Chromosome Association Study in Latin American Cohorts Identifies New Loci in Parkinson's Disease. | Leal TP et al. | — | 2023 | → |
| μ- PBWT: a lightweight r-indexing of the PBWT for storing and querying UK Biobank data. | Cozzi D et al. | — | 2023 | → |